{
  "meta": {
    "title": "00051_Late_Night_Pyq_Pyt_Marathon_-_51",
    "url": "https://brainandscalpel.vercel.app/00051-late-night-pyq-pyt-marathon-51-7eafc052.html",
    "scrapedAt": "2025-11-29T17:24:57.211Z"
  },
  "questions": [
    {
      "id": 4264,
      "choices": [
        {
          "id": 17033,
          "text": "<p><span style=\"font-size:12.0pt;\">Croup</span></p>"
        },
        {
          "id": 17034,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory papillomatosis</span></p>"
        },
        {
          "id": 17035,
          "text": "<p><span style=\"font-size:12.0pt;\">Vocal nodule</span></p>"
        },
        {
          "id": 17036,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute epiglottitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old presents with gradually progressive hoarseness of voice over three months and respiratory distress for 2 weeks. Diagnosis is: (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q1345862",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560940,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Respiratory papillomatosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical situation suggests that the child is suffering from respiratory papillomatosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Respiratory Papillomatosis (Juvenile Papillomatosis)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is the most common benign neoplasm of the larynx in children.</span></li><li><span style=\"font-size:12.0pt;\">It is caused by HPV 6 and 11.</span></li><li><span style=\"font-size:12.0pt;\">Involves supraglottic and glottic regions of larynx.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical features:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Age 3-5 years</span></li><li><span style=\"font-size:12.0pt;\">Hoarseness or aphonia</span></li><li><span style=\"font-size:12.0pt;\">Respiratory difficulty</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis is confirmed by direct laryngoscopy and biopsy</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture16.jpg\" alt=\"\" width=\"500\" height=\"378\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment consists of cold steel/ coblation/ debrider/ radiofrequency/ Laser assisted microlaryngeal surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Croup:</strong> Though croup affects young children and presents with respiratory symptoms, it is an acute condition that generally presents rapidly with a characteristic barking cough and stridor, not gradually as in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vocal nodule:</strong> Vocal nodules result from vocal cord trauma and present symmetrically on the free edge of the vocal cords at the junction of the anterior one-third and the posterior two-thirds. They typically cause hoarseness but do not lead to respiratory distress, as they do not obstruct the airway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Acute epiglottitis:</strong> This is another acute condition, presenting with rapid onset and severe symptoms including high fever, throat pain, and significant respiratory distress. The progressive nature of the symptoms described in the question does not align with the acute presentation of epiglottitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Juvenile respiratory papillomatosis should be considered in young children presenting with a gradual worsening of hoarseness and the development of respiratory symptoms. The condition highlights the need for awareness of HPV-related diseases in children and indicates the importance of early and accurate diagnosis followed by appropriate surgical intervention, which may include cold steel, coblation, debrider, radiofrequency, or laser-assisted microlaryngeal surgery to manage the growth and recurrence of papillomas effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition pg 327, 328, 343, 345, 346</strong></span></p>",
      "correct_choice_id": 17034,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20649,
      "choices": [
        {
          "id": 82559,
          "text": "<p><span style=\"font-size:12.0pt;\">Airway toileting</span></p>"
        },
        {
          "id": 82560,
          "text": "<p><span style=\"font-size:12.0pt;\">Upper airway examination</span></p>"
        },
        {
          "id": 82561,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute nasopharyngeal obstruction</span></p>"
        },
        {
          "id": 82562,
          "text": "<p><span style=\"font-size:12.0pt;\">Prolonged mechanical ventilation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;The instrument shown in the image is not used for which of the following?&nbsp; </span>(NEET PG 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/05/whatsapp-image-2023-06-12-at-190121011044.jpg\" alt=\"\" width=\"400\" height=\"215\"></span></p>",
      "unique_key": "Q1009328",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560941,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Upper airway examination</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows a tracheostomy tube, which is not used for upper airway examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tracheostomy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is a procedure where alternative airway is established when normal airway is compromised.</span></li><li><span style=\"font-size:12.0pt;\">An opening is made on the anterior wall of trachea and a tube is inserted, through which air exchange occurs between lungs and outside.</span></li><li><span style=\"font-size:12.0pt;\">It bypasses upper airway structures from nose to larynx thereby reducing the dead space by 50%.</span></li><li><span style=\"font-size:12.0pt;\">Usually done at the level of 2nd to 3rd tracheal rings.</span></li><li><span style=\"font-size:12.0pt;\">High tracheostomy (1st ring) done along with surgeries related to cancer larynx.</span></li><li><span style=\"font-size:12.0pt;\">In emergency tracheostomy, vertical incision is taken but in elective cases, horizontal incision is taken.</span></li><li><span style=\"font-size:12.0pt;\">It is generally a temporary procedure till the pathology in the upper bypassed airway clears.</span></li><li><span style=\"font-size:12.0pt;\">In some cases, like cancer larynx where laryngectomy was done, permanent tracheostomy is done.</span></li><li><span style=\"font-size:12.0pt;\">Removal of tracheostomy tube is called decannulation.</span></li><li><span style=\"font-size:12.0pt;\">Different types of tracheostomy tubes – PVC, Metallic (Chevalier-Jackson), etc.</span></li><li><span style=\"font-size:12.0pt;\">Complications of tracheostomy → surgical emphysema, hemorrhage, Apnea due to CO2 washout, Pneumothorax, Tube displacement, Tube blockage, Tracheomalacia, Subglottic stenosis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Primary Uses of a Tracheostomy Tube Include:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Airway Toileting</strong>: Facilitates the removal of secretions from the airways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Acute Nasopharyngeal Obstruction</strong>: Provides an airway bypass in cases of blockage in the upper airway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prolonged Mechanical Ventilation</strong>: Offers a secure, stable method for long-term ventilation support.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tracheostomy tubes are not used for examining the upper airway as they do not provide access or visibility to upper airway structures such as the nasal passages, pharynx, or larynx. Instead, tools like laryngoscopes or endoscopes are employed for this purpose.</span></p>",
      "correct_choice_id": 82560,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "InstrumentsBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54231,
      "choices": [
        {
          "id": 216393,
          "text": "<p><span style=\"font-size:12.0pt;\">Eustachian tube</span></p>"
        },
        {
          "id": 216394,
          "text": "<p><span style=\"font-size:12.0pt;\">IX nerve (Glossopharyngeal Nerve)</span></p>"
        },
        {
          "id": 216395,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior laryngeal nerve</span></p>"
        },
        {
          "id": 216396,
          "text": "<p><span style=\"font-size:12.0pt;\">Recurrent laryngeal nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which structures pass between superior and middle constrictor?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7825914",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560942,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) IX nerve (Glossopharyngeal Nerve)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pharyngeal constrictor muscles are organized into three main parts: the superior, middle, and inferior constrictors. Each of these muscles plays a crucial role in the mechanics of swallowing and speech.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The glossopharyngeal nerve passes between the superior and middle constrictor muscles. This is a key anatomical relationship to remember as it is crucial for the nerve supply to the pharynx.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4BRIypv.png\" width=\"705\" height=\"582\"></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Eustachian Tube:</strong> Passes through the sinus of Morgagni, not between the superior and middle constrictors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Superior Laryngeal Nerve:</strong> Passes between the middle and inferior constrictors, not the superior and middle constrictors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Recurrent Laryngeal Nerve:</strong> Passes between the inferior constrictor and the esophagus, not between the superior and middle constrictors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The IX nerve (Glossopharyngeal nerve) and the stylopharyngeus muscle pass between the superior and middle constrictor muscles of the pharynx.</span></p>",
      "correct_choice_id": 216394,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4138,
      "choices": [
        {
          "id": 16531,
          "text": "<p>A</p>"
        },
        {
          "id": 16532,
          "text": "<p>B</p>"
        },
        {
          "id": 16533,
          "text": "<p>C</p>"
        },
        {
          "id": 16534,
          "text": "<p>D</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The provided picture shows a patient who has undergone mastoidectomy. Identify the lateral semicircular canal in the image. (</span>AIIMS May 2017)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture9.jpg\" alt=\"\" width=\"300\" height=\"218\"></span></p><p>&nbsp;</p>",
      "unique_key": "Q5519883",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560943,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the given image of a post-mastoidectomy surgical field, label A corresponds to the lateral semicircular canal. The lateral semicircular canal is a crucial component of the inner ear's vestibular system, involved in maintaining balance and spatial orientation. It can be identified by its specific location relative to other anatomical landmarks visible in the image, such as the tympanic bone, mastoid tip, and the spine of Henle.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture10.jpg\" alt=\"\" width=\"500\" height=\"281\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: </strong>This label points to the posterior semicircular canal, which is a bony protrusion in the mastoid portion of the temporal bone, serving as an important landmark during mastoid surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C: </strong>This indicates the sigmoid sinus, a dural venous sinus within the skull, lying beneath the cranial bone and above the structures of the middle and inner ear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Labelled as the Tegmen, which is part of the temporal bone that forms the roof over the middle ear and mastoid antrum, shielding these structures from the intracranial contents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The lateral semicircular canal, identified at label A, is part of the vestibular system, crucial for balance and orientation.</span></p>",
      "correct_choice_id": 16531,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5262,
      "choices": [
        {
          "id": 21020,
          "text": "<p><span style=\"font-size:12.0pt;\">Facial nerve</span></p>"
        },
        {
          "id": 21021,
          "text": "<p><span style=\"font-size:12.0pt;\">Trigeminal nerve</span></p>"
        },
        {
          "id": 21022,
          "text": "<p><span style=\"font-size:12.0pt;\">Oculomotor nerve</span></p>"
        },
        {
          "id": 21023,
          "text": "<p><span style=\"font-size:12.0pt;\">Glossopharyngeal nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with the complaint of inability to close the eye, drooling of saliva, and deviation of the angle of the mouth. Which of the following nerves is most likely to be affected? (NEET PG 2022)</span></p>",
      "unique_key": "Q1920154",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560944,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Facial nerve</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical features of inability to close the eye, drooling of saliva, and deviation of the angle of the mouth are suggestive of paralysis of the facial nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bell's palsy is defined as idiopathic, peripheral facial paralysis or paresis of acute onset.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Etiology –</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Viral infection&nbsp; - herpes simplex, herpes zoster, EBV</span></li><li><span style=\"font-size:12.0pt;\">Vascular ischemia</span></li><li><span style=\"font-size:12.0pt;\">Heredity – narrow fallopian canal</span></li><li><span style=\"font-size:12.0pt;\">Autoimmune</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical features -</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Onset is sudden. Patient is unable to close his eyes. On attempting to close the eye, the eyeball turns up and out (Bell phenomenon). Saliva dribbles from the angle of mouth. Face becomes asymmetrical. Tears flow down from the eye (epiphora). Pain in the ear may precede or accompany nerve paralysis. Some complain of noise intolerance (stapedial paralysis) or loss of taste (involvement of chorda tympani). Paralysis may be complete or incomplete. Bell palsy is recurrent in 3–10% of patients.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/5_hcsmvNT.jpg\" alt=\"\" width=\"700\" height=\"604\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bell's palsy is a diagnosis of exclusion. All other possible causes of facial paralysis should be ruled out by investigations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment of Bell's palsy -</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Prednisolone is the drug of choice. If a patient reports within 1 week, the adult dose of prednisolone is 1 mg/kg/day divided into morning and evening doses for 5 days. Patient is seen on the fifth day. If paralysis is incomplete or is recovering, the dose is tapered during the next 5 days. If paralysis remains complete, the same dose is continued for another 10 days and thereafter tapered in next 5 days (total of 20 days).</span></li><li><span style=\"font-size:12.0pt;\">Eye care to prevent keratitis</span></li><li><span style=\"font-size:12.0pt;\">Analgesic for ear pain</span></li><li><span style=\"font-size:12.0pt;\">Physiotherapy</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Trigeminal nerve:</strong> Mainly responsible for facial sensation, not motor control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Oculomotor nerve:</strong> Primarily influences eye movement; paralysis typically results in ptosis and pupillary dilation, not facial drooping.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Glossopharyngeal nerve:</strong> Affects swallowing and taste sensations at the back of the tongue; does not cause facial drooping or affect eye closure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Prompt recognition and treatment of facial nerve paralysis are crucial for improving outcomes and preventing permanent damage. Treatment primarily involves medication to reduce inflammation and supportive care, especially for eye protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 103, 104</strong></span></p>",
      "correct_choice_id": 21020,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61083,
      "choices": [
        {
          "id": 243613,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vocal cord nodules</span></span></span></p>"
        },
        {
          "id": 243614,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laryngeal papilloma</span></span></span></p>"
        },
        {
          "id": 243615,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vocal cord polyp</span></span></span></p>"
        },
        {
          "id": 243616,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reinke&rsquo;s edema</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 4-year-old boy is brought to the ENT clinic by his parents due to persistent hoarseness and difficulty breathing, which have progressively worsened over the past several months. The parents report that his voice has become increasingly raspy, and he often struggles with noisy breathing, especially during physical activity. There is no history of recent respiratory infections or trauma. On flexible fiberoptic laryngoscopy, lesions observed on his vocal cords (as shown in below image). The physician suspects a viral etiology associated with these lesions. What is the diagnosis of the vocal cord lesion shown in the image?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/picture1_988y1Ks.jpg\" style=\"height:213px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q9592414",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560945,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: B. Laryngeal papilloma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laryngeal papillomatosis, commonly referred to as laryngeal papilloma, is the most common benign neoplasm of the larynx in children. It is caused by human papillomavirus (HPV) types 6 and 11 and is often acquired at birth from mothers with genital HPV infection. The lesions typically present as wart-like growths on the vocal cords, affecting the glottic and supraglottic regions but can extend to other parts of the respiratory tract. Patients usually present with hoarseness, stridor, or respiratory difficulty, and the diagnosis is confirmed through laryngoscopy and biopsy. Recurrence is common, and treatment involves microlaryngoscopy with CO2 laser excision, with the primary goal of maintaining airway patency and preserving vocal function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Vocal cord nodules:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These are benign growths on the vocal cords caused by vocal strain or overuse, presenting as bilateral, symmetrical lesions. They typically do not have the viral etiology or recurrence pattern seen in laryngeal papillomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C. Vocal cord polyp:</strong> Polyps are unilateral, fluid-filled lesions that develop due to vocal trauma, smoking, or other irritants. Unlike papillomas, they are not caused by HPV and are generally managed with conservative voice therapy or surgical removal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>D. Reinke&rsquo;s edema:</strong> This condition involves the swelling of the vocal cords due to fluid accumulation, commonly associated with smoking or vocal overuse. It presents with a deep, gravelly voice but lacks the warty appearance of papillomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laryngeal papillomatosis is caused by HPV types 6 and 11 and is characterized by recurrent wart-like lesions on the vocal cords, leading to hoarseness and respiratory difficulties. Early recognition and treatment through microlaryngoscopy with CO2 laser excision are essential to manage symptoms, maintain airway patency, and preserve vocal quality.</span></span></span></p>",
      "correct_choice_id": 243614,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24678,
      "choices": [
        {
          "id": 98673,
          "text": "<p><span style=\"font-size:12.0pt;\">1-2-3-4-5</span></p>"
        },
        {
          "id": 98674,
          "text": "<p><span style=\"font-size:12.0pt;\">5-4-3-2-1</span></p>"
        },
        {
          "id": 98675,
          "text": "<p><span style=\"font-size:12.0pt;\">2-1-3-4-5</span></p>"
        },
        {
          "id": 98676,
          "text": "<p><span style=\"font-size:12.0pt;\">3-4-5-1-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrange the following in the sequence of auditory pathway:</span><span style=\"font-size:16px;\"><i>(INICET MAY 2023)</i></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Cochlear nucleus</span></li><li><span style=\"font-size:12.0pt;\">Spiral ganglion</span></li><li><span style=\"font-size:12.0pt;\">Superior olivary nucleus</span></li><li><span style=\"font-size:12.0pt;\">Inferior colliculus</span></li><li><span style=\"font-size:12.0pt;\">Medial geniculate body</span></li></ol><p>&nbsp;</p>",
      "unique_key": "Q6460047",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560946,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 2-1-3-4-5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct sequence of the auditory pathway is spiral ganglion - cochlear nucleus - superior olivary nucleus - inferior colliculus - medial geniculate body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Spiral Ganglion </strong>: The spiral ganglion is situated in Rosenthal's canal and contains bipolar cells. The dendrites of these bipolar cells join to form the cochlear branch of the vestibulocochlear nerve, which ends in the cochlear nuclei.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Cochlear Nucleus </strong>: The cochlear nerve fibers synapse in the cochlear nuclei located in the brainstem.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Superior Olivary Nucleus </strong>: After the cochlear nucleus, the pathway proceeds to the superior olivary nucleus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Inferior Colliculus </strong>: From the superior olivary nucleus, the auditory signals travel to the inferior colliculus in the midbrain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. Medial Geniculate Body </strong>: The signals are then relayed to the medial geniculate body of the thalamus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct sequence of structures involved in the auditory pathway from the periphery to the center is (<strong>E COLI MA</strong>).</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Eighth (Vestibulocochlear) nerve</span></li><li><span style=\"font-size:12.0pt;\">Cochlear Nucleus</span></li><li><span style=\"font-size:12.0pt;\">Superior Olivary nucleus</span></li><li><span style=\"font-size:12.0pt;\">Lateral lemniscus</span></li><li><span style=\"font-size:12.0pt;\">Inferior colliculus</span></li><li><span style=\"font-size:12.0pt;\">Medial geniculate body</span></li><li><span style=\"font-size:12.0pt;\">Auditory cortex</span></li></ol><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/inicet-may-2023-ent.jpg\" alt=\"\" width=\"700\" height=\"736\"></span></p>",
      "correct_choice_id": 98675,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4146,
      "choices": [
        {
          "id": 16563,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage I</span></p>"
        },
        {
          "id": 16564,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage II</span></p>"
        },
        {
          "id": 16565,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage III</span></p>"
        },
        {
          "id": 16566,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person presents with a tongue ulcer persisting for 3 months. Upon examination, a lesion measuring 3.5 cm x 2.5 cm is observed, accompanied by an 8 mm area of hardened tissue. No lymph node enlargement is detected. According to the 8th AJCC guidelines, what stage does this lesion correspond to? (</span>AIIMS May 2018)</p>",
      "unique_key": "Q4350029",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560947,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Stage II</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the given case can be classified as <strong>T2N0M0</strong> as per AJCC 2002 as the size of the lesion is between 2-4 cm (T2) with no nodal (N0) or distant metastasis (M0) and that will come under Stage II disease.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-163941.png\" alt=\"\" width=\"800\" height=\"634\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Stage I:</strong> This stage would be applicable for T1 tumors, which are 2 cm or less in greatest dimension, and does not fit the description of the lesion presented.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Stage III:</strong> This stage would involve either T3 tumors, which are greater than 4 cm, or any T1-T3 tumors with N1 lymph node involvement, neither of which applies to this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Stage IV:</strong> This stage is reserved for more advanced disease involving T4 tumors, any tumor with N2 or N3 lymph node involvement, or distant metastasis (M1), which are not applicable in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/How%20to%20use%20the%20App%20-%20Copy.png\" width=\"844\" height=\"720\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition pg 256</strong></span></p>",
      "correct_choice_id": 16564,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43275,
      "choices": [
        {
          "id": 172767,
          "text": "<p><span style=\"font-size:12pt;\">1, 2 and 5 are correct</span></p>"
        },
        {
          "id": 172768,
          "text": "<p><span style=\"font-size:12pt;\">1, 2 and 3 are correct</span></p>"
        },
        {
          "id": 172769,
          "text": "<p><span style=\"font-size:12pt;\">All are correct</span></p>"
        },
        {
          "id": 172770,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4 and 5 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Mark the correct statement/s about Inner and Outer hair cells. (INICET Nov 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Inner hair cells are in a single row and transmit auditory impulses</span></li><li><span style=\"font-size:16px;\">Outer hair cells are in 3-4 rows and modulate function of inner hair cells</span></li><li><span style=\"font-size:16px;\">Outer hair cells are more responsible for movement of tectorial membrane</span></li><li><span style=\"font-size:16px;\">Inner hair cells are in single row and modulate function of outer hair cells</span></li><li><span style=\"font-size:16px;\">Outer and inner hair cells are present in the ratio 3:1</span></li></ol>",
      "unique_key": "Q3539279",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560948,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p style=\"text-align:justify;\"><strong>Ans. A) 1, 2 and 5 are correct&nbsp;</strong></p><p style=\"text-align:justify;\">This choice correctly identifies that inner hair cells transmit auditory impulses, outer hair cells are in multiple rows and aid in the functionality related to cochlear amplification, and that there is a numerical dominance of outer hair cells compared to inner hair cells.&nbsp;</p><p style=\"text-align:justify;\">The correct statements regarding the roles and arrangements of inner and outer hair cells within the cochlea, based on the options given, are as follows:</p><p style=\"text-align:justify;\"><strong>1. Inner hair cells are in a single row and transmit auditory impulses</strong>: This statement is correct. Inner hair cells are primarily responsible for transmitting auditory signals to the brain. They are fewer in number compared to outer hair cells and are arranged in a single row along the length of the cochlea.</p><p style=\"text-align:justify;\"><strong>2. Outer hair cells are in 3-4 rows and modulate the function of inner hair cells</strong>: This is correct. Outer hair cells are indeed arranged in 3-4 rows. They play a crucial role in amplifying and fine-tuning the vibrations within the cochlea through their motility, which affects how the inner hair cells respond to sound.&nbsp;</p><p style=\"text-align:justify;\"><strong>5. Outer and inner hair cells are present in the ratio 3:1</strong>: This statement is&nbsp; correct. There are significantly more outer hair cells than inner hair cells, typically at a ratio close to 3:1, reflecting their arrangement in multiple rows compared to the single row of inner hair cells. <img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DV28LkC.png\" width=\"600\" height=\"214\"></p><p style=\"text-align:justify;\"><strong>Other Options:</strong></p><p style=\"text-align:justify;\"><strong>3. Outer hair cells are more responsible for the movement of the tectorial membrane</strong>: This statement is incorrect. Outer hair cells do contribute to the movement of the tectorial membrane through their motility and changes in length, but it's more accurate to say they influence the fluid mechanics around the inner hair cells, affecting how the tectorial membrane interacts with them.</p><p style=\"text-align:justify;\"><strong>4. Inner hair cells are in a single row and modulate function of outer hair cells</strong>: This statement is incorrect. Inner hair cells do not modulate the function of outer hair cells; rather, they function primarily as sensory transducers sending information to the brain.</p><p style=\"text-align:justify;\"><strong>Educational Objective:</strong>&nbsp;</p><p style=\"text-align:justify;\">The correct statements about inner and outer hair cells are that inner hair cells are in a single row and transmit auditory impulses, outer hair cells are in 3-4 rows and help modulate cochlear mechanics, and the ratio of outer to inner hair cells is about 3:1.</p>",
      "correct_choice_id": 172767,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4173,
      "choices": [
        {
          "id": 16671,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenoids</span></p>"
        },
        {
          "id": 16672,
          "text": "<p><span style=\"font-size:12.0pt;\">Arytenoids</span></p>"
        },
        {
          "id": 16673,
          "text": "<p><span style=\"font-size:12.0pt;\">Torus tubarius</span></p>"
        },
        {
          "id": 16674,
          "text": "<p><span style=\"font-size:12.0pt;\">Upper surface of soft palate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A senior ENT specialist at the hospital is conducting the clinical examination depicted in the provided image. Which of the subsequent anatomical structures will not be visible to him? (</span>INICET May 2020)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/15_AnVZpUE.jpg\" alt=\"\" width=\"300\" height=\"218\"></span></p>",
      "unique_key": "Q6648803",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560949,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Arytenoids</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While conducting a posterior rhinoscopy with the held post-nasal mirror, the specialist would not have a view of the arytenoids.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Arytenoids are seen on indirect laryngoscopy.</span></li><li><span style=\"font-size:12.0pt;\">The posterior rhinoscopy mirror has two bends in the shaft and is bayonet shaped.</span></li><li><span style=\"font-size:12.0pt;\">The structures seen in posterior rhinoscopy are:</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/16.jpg\" alt=\"\" width=\"700\" height=\"469\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Adenoids:</strong> These are clearly visible during posterior rhinoscopy, which is aimed at examining the nasopharynx, where the adenoids are located.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Torus tubarius:</strong> This structure, which surrounds the pharyngeal opening of the Eustachian tube, is also visible during a posterior rhinoscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Upper surface of soft palate:</strong> This area can be inspected during posterior rhinoscopy for signs of inflammation, lesions, or other abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The arytenoids are viewed using indirect laryngoscopy, not posterior rhinoscopy, due to their location in the larynx. Posterior rhinoscopy provides visualization of the nasopharyngeal region, aiding in the assessment of structures like adenoids, torus tubarius, and the upper surface of the soft palate, important for diagnosing various nasopharyngeal conditions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Structures seen on indirect laryngoscopy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/17.jpg\" alt=\"\" width=\"700\" height=\"365\"></strong></span></p>",
      "correct_choice_id": 16672,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5190,
      "choices": [
        {
          "id": 20733,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure of migration of desquamated epithelium along posterior metal wall</span></p>"
        },
        {
          "id": 20734,
          "text": "<p><span style=\"font-size:12.0pt;\">Widening of meatus and facial nerve palsy might be seen</span></p>"
        },
        {
          "id": 20735,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated bronchiectasis and sinusitis</span></p>"
        },
        {
          "id": 20736,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following statements is true about keratosis obturans? (NEET PG 2019)</span></p>",
      "unique_key": "Q5285355",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560950,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) All of the above</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All of the above statements are true regarding keratosis obturans.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Collection of a pearly white mass of desquamated epithelial cells in the deep meatus is called keratosis obturans. This, by its pressure effect, causes absorption of bone leading to widening of the meatus so much so that facial nerves may be exposed and paralyzed.</span></li><li><span style=\"font-size:12.0pt;\">Presenting symptoms may be pain in the ear, hearing loss, tinnitus and sometimes ear discharge. It may sometimes be associated with bronchiectasis and chronic sinusitis.</span></li><li><span style=\"font-size:12.0pt;\">On examination, the ear canal may be full of pearly white mass of keratin material disposed in several layers. Removal of this mass may show widening of bony meatus with ulceration and even granuloma formation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/21/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_220.jpg\" alt=\"\" width=\"300\" height=\"287\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Keratotic mass is removed either by syringing or instrumentation, similar to the techniques employed for impacted wax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Keratosis obturans is characterized by the accumulation of epithelial cells in the ear canal, leading to potential structural damage and associated symptoms. Its management requires careful removal of the buildup and monitoring for complications such as facial nerve palsy. Awareness of its association with bronchiectasis and sinusitis is crucial for comprehensive patient care.</span></p>",
      "correct_choice_id": 20736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4231,
      "choices": [
        {
          "id": 16901,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat surgery</span></p>"
        },
        {
          "id": 16902,
          "text": "<p><span style=\"font-size:12.0pt;\">Macrolides for 4 months</span></p>"
        },
        {
          "id": 16903,
          "text": "<p><span style=\"font-size:12.0pt;\">Steroid irrigation and antihistamines</span></p>"
        },
        {
          "id": 16904,
          "text": "<p><span style=\"font-size:12.0pt;\">Biological therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old female patient presents with complaints of nasal obstruction and post-nasal drip. There is a past history of FESS (Functional endoscopic sinus surgery) for failed conservative management 5 years ago. Uncinectomy and maxillary ostium dilation was done during the previous FESS. A DNE done now shows patent ostia and mucosal edema of the maxillary sinus lining. What is the next best step in management? (INICET MAY 2022)</span></p>",
      "unique_key": "Q7356811",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560951,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Steroid irrigation and antihistamines</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The next best step in management in this patient is steroid irrigation and antihistamines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient who had previously undergone FESS 5 years ago for failed medical management now has nasal obstruction and post-nasal drip suggestive of acute rhinosinusitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute rhinosinusitis usually develops along with viral upper respiratory tract infection due to mucosal swelling causing obstruction of the sinus ostia. Persistent or worsening symptoms even after 10 days with fever and purulent discharge indicates secondary bacterial infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment initially is symptomatic with -</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">First line of treatment - Nasal steroid irrigation, decongestants, and antihistamines</span></li><li><span style=\"font-size:12.0pt;\">In cases of secondary bacterial infection antibiotics are indicated. Amoxyclav is the drug of choice.</span></li><li><span style=\"font-size:12.0pt;\">Biological therapy is not used in the treatment of sinusitis. It may be used in cases of refractory polyp.</span></li><li><span style=\"font-size:12.0pt;\">Revision surgery is indicated only when maximal medical therapy has failed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Repeat Surgery</strong>: Indicated only if there are anatomical obstructions or complications that cannot be managed medically. In this case, the DNE shows patent ostia, so repeat surgery is not indicated without further evidence of structural issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Macrolides for 4 months</strong>: Could be considered for their anti-inflammatory properties in some chronic rhinosinusitis cases, but there is no mention of bacterial infection needing long-term antibiotics, making this less suitable than symptomatic management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Biological Therapy</strong>: Mainly used for refractory cases with specific underlying conditions such as severe asthma or nasal polyps, which is not indicated here based on the provided scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient with nasal obstruction and post-nasal drip post-FESS with no current acute infection or structural issues, conservative management using steroid irrigation and antihistamines is recommended to manage inflammation and alleviate symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 213, 214</strong></span></p>",
      "correct_choice_id": 16903,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61087,
      "choices": [
        {
          "id": 243629,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Earache</span></span></span></p>"
        },
        {
          "id": 243630,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multiple tympanic membrane perforations</span></span></span></p>"
        },
        {
          "id": 243631,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Painless ear discharge</span></span></span></p>"
        },
        {
          "id": 243632,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Facial paralysis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 50-year-old man with a known history of pulmonary tuberculosis presents to the ENT clinic with a persistent symptoms inhis right ear that has been ongoing for several months. He has noticed progressive hearing loss. Otoscopic examination reveals signs of chronic mastoid involvement.. The physician suspects tuberculous otitis media given the patient&#39;s history and clinical findings. Which of the following is not a characteristic of tuberculous otitis media?</span></span></span></p>",
      "unique_key": "Q2826855",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560952,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Earache</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tuberculous otitis media is a chronic form of middle ear infection caused by the spread of tuberculosis from another site, commonly the lungs. The disease progresses slowly and insidiously, leading to painless necrosis of the tympanic membrane, which often results in multiple perforations that can coalesce into a larger defect. Patients typically present with painless, foul-smelling ear discharge, hearing loss, and possible complications like facial paralysis, mastoiditis, and postauricular fistulas. Unlike other forms of otitis media, earache is notably absent in tuberculous otitis media, making the lack of pain a distinguishing feature of this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B. Multiple tympanic membrane perforations:</strong> This is a common feature of tuberculous otitis media, where the disease causes multiple small perforations that may merge into a larger one due to the painless necrosis of the tympanic membrane.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Painless ear discharge:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The ear discharge in tuberculous otitis media is characteristically foul-smelling and painless, differentiating it from other ear infections that often cause pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Facial paralysis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Facial nerve paralysis can occur due to the spread of infection to the facial nerve, commonly seen in advanced cases of tuberculous otitis media.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tuberculous otitis media is a painless middle ear infection associated with multiple tympanic membrane perforations, foul-smelling discharge, and potential complications such as facial paralysis and mastoiditis. Recognizing the absence of earache is crucial for distinguishing this condition from other types of otitis media, aiding in timely and appropriate management.</span></span></span></p>",
      "correct_choice_id": 243629,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4280,
      "choices": [
        {
          "id": 17097,
          "text": "<p><span style=\"font-size:12.0pt;\">Give corticosteroids</span></p>"
        },
        {
          "id": 17098,
          "text": "<p><span style=\"font-size:12.0pt;\">Cessation of smoking and do biopsy</span></p>"
        },
        {
          "id": 17099,
          "text": "<p><span style=\"font-size:12.0pt;\">Lifestyle modifications</span></p>"
        },
        {
          "id": 17100,
          "text": "<p><span style=\"font-size:12.0pt;\">Injection vitamin B12</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient present with oral cavity findings as seen in the image below. He is a smoker. What would you choose as your next step in the management of this patient? (</span>AIIMS Nov 2018)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/27_mhd3pxQ.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p><p>&nbsp;</p>",
      "unique_key": "Q6840923",
      "question_audio": null,
      "question_video": null,
      "map_id": 13560953,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cessation of smoking and do biopsy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The next step of management of this patient will be cessation of smoking and do a biopsy.</span></li><li><span style=\"font-size:12.0pt;\">The patient is a chronic smoker and the following image shows leukoplakia. Leukoplakia is a premalignant condition of the oral cavity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The management include:&nbsp;</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\">Elimination of associated aetiological factors and biopsy of the lesion. Many of the lesions will disappear spontaneously if the causative agent is removed.</span></li><li><span style=\"font-size:12.0pt;\">In lesions with higher potential for malignant change, a biopsy is taken to rule out malignancy.</span></li><li><span style=\"font-size:12.0pt;\">In suspicious small lesions, surgical excision or ablation with laser or cryotherapy can be done.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A photographic record of the lesion is useful for long term follow up.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Give corticosteroids:</strong> There is no role for corticosteroids in the treatment of leukoplakia as they do not address the potential for malignant transformation or the underlying causes of the lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lifestyle Modifications:</strong> While beneficial overall, lifestyle changes alone are insufficient for managing a lesion with potential malignancy. Specific interventions like quitting smoking are required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Injection vitamin B12:</strong> There is no indication that vitamin B12 injections would be effective in treating leukoplakia unless there is a specific deficiency that also needs addressing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For leukoplakia, particularly in smokers, the primary management strategy includes cessation of smoking and histological examination through biopsy. This is crucial not only to assess the current state of the lesion but also to guide further therapeutic decisions which may include surgical excision, laser ablation, or cryotherapy depending on the biopsy results. Regular monitoring and photographic documentation of the lesion are also important for long-term follow-up.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 253</strong></span></p>",
      "correct_choice_id": 17098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4405,
      "choices": [
        {
          "id": 17597,
          "text": "<p><span style=\"font-size:12.0pt;\">Grade 1</span></p>"
        },
        {
          "id": 17598,
          "text": "<p><span style=\"font-size:12.0pt;\">Grade 2</span></p>"
        },
        {
          "id": 17599,
          "text": "<p><span style=\"font-size:12.0pt;\">Grade 3</span></p>"
        },
        {
          "id": 17600,
          "text": "<p><span style=\"font-size:12.0pt;\">Grade 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the grade of tympanic membrane retraction shown in the image?</span></p><p>(INICET NOVEMBER 2022)&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/picture51.jpg\" alt=\"\" width=\"300\" height=\"305\"></p>",
      "unique_key": "Q9736999",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561344,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><strong>✅ Correct Answer: B. Grade 2</strong></p><hr><p><strong>📸 Image Analysis:</strong></p><p><img class=\"image_resized\" style=\"aspect-ratio:1057/1073;width:32.2%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_yT9rPVQ.jpeg\" width=\"1057\" height=\"1073\"></p><p><strong>The otoscopic image shows a retracted pars tensa where deeper middle ear structures like the long process of the incus and incudostapedial joint are visible. The lateral process of the malleus is prominently seen, and the tympanic membrane appears pulled medially, but it is not adherent to the promontory, and air is still visible in the middle ear. This presentation is typical of Grade 2 retraction.</strong></p><hr><p><strong>🔍 Explanation of Options:</strong></p><p style=\"margin-left:36.0pt;\"><strong>Option A: Grade 1</strong></p><p style=\"margin-left:36.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_eg78a1j.png\" width=\"395\" height=\"188\"></strong></p><p style=\"margin-left:36.0pt;\"><strong>In Grade 1 pars tensa retraction, there is only mild inward retraction. The cone of light is lost, the fibrous annulus appears more prominent, and the handle of the malleus becomes more medialized. Importantly, there is no contact with the ossicles, and ossicular landmarks like the incus are not visible. This does not match the findings seen in the image.</strong></p><p style=\"margin-left:36.0pt;\">&nbsp;</p><p style=\"margin-left:36.0pt;\"><strong>Option B: Grade 2</strong></p><p style=\"margin-left:36.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_SqabcDB.png\" width=\"370\" height=\"187\"></strong></p><p style=\"margin-left:36.0pt;\"><strong>Grade 2 retraction is more severe than Grade 1, and the pars tensa is retracted to the extent that it touches the long process of the incus. Deeper structures like the incudostapedial joint, round window niche, and even the horizontal facial canal may be visible. The tympanic membrane still retains some mobility and is not adherent to the promontory. This fits the otoscopic image exactly, where ossicular structures are seen but no signs of complete adhesion are present.</strong></p><p style=\"margin-left:36.0pt;\">&nbsp;</p><p style=\"margin-left:36.0pt;\"><strong>Option C: Grade 3</strong></p><p style=\"margin-left:36.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_O7lqwRU.png\" width=\"287\" height=\"149\"></strong></p><p style=\"margin-left:36.0pt;\"><strong>In Grade 3 retraction, the tympanic membrane is severely retracted and becomes adherent to the promontory, forming what is called an atelectatic membrane. Although some air may still remain in the middle ear, the drum is essentially collapsed onto the medial wall. This condition is more advanced than what is seen in the current image.</strong></p><p style=\"margin-left:36.0pt;\">&nbsp;</p><p style=\"margin-left:36.0pt;\"><strong>Option D: Grade 4</strong></p><p style=\"margin-left:36.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_mkVLDUy.png\" width=\"288\" height=\"149\"></strong></p><p style=\"margin-left:36.0pt;\"><strong>This is the most severe stage where the entire tympanic membrane is stuck to the promontory, and there is complete loss of middle ear aeration. It often leads to adhesive otitis media, and ossicular erosion (such as necrosis of the incus) may occur. This is clearly not the case here, as ossicles are intact and the membrane is not fully adherent.</strong></p><hr><p><strong>🧠 Educational Objective:</strong></p><p><strong>Grade 2 pars tensa retraction is identified when the tympanic membrane retracts to touch the long process of the incus without adhering to the promontory, often revealing middle ear ossicles such as the incudostapedial joint.</strong></p><p>&nbsp;</p>",
      "correct_choice_id": 17598,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5230,
      "choices": [
        {
          "id": 20892,
          "text": "<p><span style=\"font-size:12.0pt;\">Shift to OT, remove the clots, and cauterize/ligate the vessel</span></p>"
        },
        {
          "id": 20893,
          "text": "<p><span style=\"font-size:12.0pt;\">Shift to OT, start IV antibiotics, and pack the tonsillar fossa</span></p>"
        },
        {
          "id": 20894,
          "text": "<p><span style=\"font-size:12.0pt;\">Give anticoagulants, repeated gargling, and wait for 24 hours</span></p>"
        },
        {
          "id": 20895,
          "text": "<p><span style=\"font-size:12.0pt;\">Do blood transfusion and wait and watch</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient post-tonsillectomy in the recovery room starts bleeding from the operative site. On examination, blood clots are seen. What will be your immediate management? (NEET PG 2021)</span></p>",
      "unique_key": "Q3445958",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561345,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Shift to OT, remove the clots, and cauterize/ligate the vessel</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical picture is suggestive of reactionary hemorrhage post-tonsillectomy and the immediate management is to shift the patient to OT, remove the clots, and cauterize/ligate the bleeding vessel.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hemorrhage is a common complication of tonsillectomy. It can be primary, reactionary, or secondary:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Primary hemorrhage</strong> occurs at the time of operation. It can be controlled by pressure, ligation, or electrocoagulation of the bleeding vessels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Reactionary hemorrhage</strong> occurs within 24 hours. It may be due to dislodgement of the clot, slippage of ligature, or blood pressure returning to normal. It is managed by removal of clot and application of pressure or vasoconstrictor. Ligation or electrocoagulation of the bleeding vessels is done under anesthesia if the above measures fail.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Secondary hemorrhage</strong> is usually seen between the 5th to 10th postoperative day. It is due to sepsis and premature separation of the membrane. Removal of the clot, topical application of dilute adrenaline or hydrogen peroxide with pressure usually suffice. IV antibiotics are given and the bleeding vessel is electro coagulated or ligated if bleeding continues.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The immediate return to the OT for direct intervention is essential in managing post-tonsillectomy bleeding. Ensuring the bleeding vessel is adequately addressed through cauterization or ligation can prevent further complications and promote healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 504, 505</strong></span></p>",
      "correct_choice_id": 20892,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24843,
      "choices": [
        {
          "id": 99333,
          "text": "<p><span style=\"font-size:12.0pt;\">Midline lethal granuloma</span></p>"
        },
        {
          "id": 99334,
          "text": "<p><span style=\"font-size:12.0pt;\">Foreign body granuloma</span></p>"
        },
        {
          "id": 99335,
          "text": "<p><span style=\"font-size:12.0pt;\">Phycomycosis</span></p>"
        },
        {
          "id": 99336,
          "text": "<p><span style=\"font-size:12.0pt;\">IgG4 granuloma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with a history of minor trauma 20 days back with a piece of wood. He presented as shown in the image. CT scan revealed clear sinuses and the presence of subcutaneous nodules. Microscopy of the tissue sections are positive to PAS and positive on Gomori methamine silver stain. What is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/ranula-1.jpg\" alt=\"\" width=\"200\" height=\"275\"></span></p>",
      "unique_key": "Q4962239",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561346,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Phycomycosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario points to a diagnosis of Phycomycosis /Mucormycosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is fungal infection of nose and paranasal sinuses which may prove rapidly fatal. It is seen in uncontrolled diabetics or in those taking immunosuppressive drugs.</span></p><p><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>PATHOLOGY</strong> – From the nose and sinuses, infection can spread to orbit, cribriform plate, meninges and brain. The rapid destruction associated with the disease is due to affinity of the fungus to invade the arteries and cause endothelial damage and thrombosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CLINICAL FEATURES</strong> – Black necrotic mass filling the nasal cavity and eroding the septum and hard palate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>DIAGNOSIS</strong> – Special stains help to identify the fungus in tissue sections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Black turbinate sign is seen on contrast MRI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>TREATMENT</strong> – Amphotericin B and surgical debridement of the affected tissues and control of underlying predisposing cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Midline lethal granuloma</strong>: Primarily involves destructive lesions of the midline facial structures but lacks the fungal component.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Foreign body granuloma</strong>: Typically arises from a reaction to a foreign material but would not cause the extensive symptoms or be positive on the fungal stains used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IgG4 granuloma</strong>: Associated with elevated levels of IgG4 and typically presents with tumefactive lesions, not primarily infectious.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phycomycosis is a serious fungal infection affecting mainly the nasal passages and sinuses, identifiable by special staining techniques and known for its aggressive, potentially fatal progression requiring prompt treatment with antifungals and surgery.</span></p>",
      "correct_choice_id": 99335,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4152,
      "choices": [
        {
          "id": 16587,
          "text": "<p><span style=\"font-size:12.0pt;\">Tail of parotid</span></p>"
        },
        {
          "id": 16588,
          "text": "<p><span style=\"font-size:12.0pt;\">Sublingual gland</span></p>"
        },
        {
          "id": 16589,
          "text": "<p><span style=\"font-size:12.0pt;\">Submandibular gland</span></p>"
        },
        {
          "id": 16590,
          "text": "<p><span style=\"font-size:12.0pt;\">Level 2b lymph nodes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these structures are retained during radical neck dissection? (NEET PG 2019)</span></p>",
      "unique_key": "Q8103895",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561347,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Sublingual gland</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a radical neck dissection, the aim is to remove extensive lymphatic tissue potentially involved with malignancies, but the procedure generally spares certain non-lymphatic structures unless directly involved by the tumor. The sublingual gland, which is located under the floor of the mouth, is not typically removed during a radical neck dissection because it is not within the field of the lymph node groups that are typically excised. This gland remains intact unless the specific tumor pathology dictates otherwise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tail of parotid:</strong> The tail of the parotid may be removed if it is involved with the tumor or if the dissection needs to be extended to ensure comprehensive removal of cancerous tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Submandibular gland:</strong> This gland is typically removed during radical neck dissections because it lies within the Level I lymph nodes, which are included in the dissection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Level 2b lymph nodes:</strong> These are generally removed in a radical neck dissection, which traditionally includes the removal of lymph nodes from Levels I to V.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-174142.png\" alt=\"\" width=\"1000\" height=\"929\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition Page No. 442; Stell and Maran 5<sup>th</sup> edition Page No. 710</strong></span></p>",
      "correct_choice_id": 16588,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4335,
      "choices": [
        {
          "id": 17317,
          "text": "<p><span style=\"font-size:12.0pt;\">Perilymphatic fistula</span></p>"
        },
        {
          "id": 17318,
          "text": "<p><span style=\"font-size:12.0pt;\">Labyrinthitis</span></p>"
        },
        {
          "id": 17319,
          "text": "<p><span style=\"font-size:12.0pt;\">Paget's disease</span></p>"
        },
        {
          "id": 17320,
          "text": "<p><span style=\"font-size:12.0pt;\">Vestibular schwannoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with vertigo, tinnitus, and head tilt. He underwent myringoplasty for the safe type of chronic suppurative otitis media (CSOM) 6 months back. What is your diagnosis? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q5899280",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561348,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Perilymphatic fistula</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The clinical scenario with symptoms of vertigo, tinnitus, and head tilt and history of myringoplasty done for CSOM suggest that the diagnosis is perilymphatic fistula.</span></li><li><span style=\"font-size:12.0pt;\">A peri-lymphatic fistula is an abnormal communication between the inner ear and the middle ear that can allow perilymph to leak from the cochlea or vestibule, most commonly through the round or oval window.</span></li><li><span style=\"font-size:12.0pt;\">Precipitating causes include surgery, blunt trauma, penetrating trauma, barotrauma, infection, cholesteatoma, or sudden changes in CSF pressure as can occur with straining, sneezing, or Valsalva’s maneuver. Congenital ear abnormalities may predispose to perilymph leaks. Spontaneous perilymph fistulae are rare.</span></li><li><span style=\"font-size:12.0pt;\">The clinical picture of perilymph fistulae is variable, with symptoms ranging from mild to incapacitating. Vertigo, or more often unsteadiness, is the most common symptom. Hearing loss, tinnitus, or aural fullness may be present. A thorough history inquiring about activities such as trauma, scuba diving, flying, and straining is critical in the diagnosis of this disorder as the symptoms are vague and coincident with other vestibular disorders. Fistula test is positive.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Investigations</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HRCT temporal bone has high sensitivity in detecting peri lymphatic fistula.</span></li><li><span style=\"font-size:12.0pt;\">A combination of CT and MRI diagnose almost 100% of cases.</span></li><li><span style=\"font-size:12.0pt;\">Other tests include audiometry and electrocochleography.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Management&nbsp;</strong>of a peri-lymphatic fistula is either by conservative or surgical methods. Conservative therapy includes avoiding anything that can increase inner ear or intracranial pressure and the use of intratympanic steroids in acute decompensation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Labyrinthitis</strong> presents with vestibular symptoms like sudden onset of persistent vertigo with associated symptoms such as nausea, vomiting, sweating and pallor and sensorineural hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Paget's&nbsp;disease</strong> of bone usually presents with hearing loss as a prominent feature, when the skull is involved. It is not associated with a history of surgery, trauma or vestibulocochlear symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vestibular Schwannoma</strong>, also called as acoustic neuroma is a tumor that arises from the Schwann cells of the vestibular, but rarely from the cochlear division of vestibulocochlear nerve within the internal auditory canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Perilymphatic fistula should be suspected in patients presenting with vestibular symptoms following ear surgery, particularly when associated with activities that change intracranial or middle ear pressure. Diagnosis is largely based on clinical history, symptomatology, and specific imaging tests.</span></p>",
      "correct_choice_id": 17317,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4299,
      "choices": [
        {
          "id": 17173,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 17174,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 17175,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        },
        {
          "id": 17176,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these labeled structures represents a division of the internal carotid artery? (</span>AIIMS Nov 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/31_sui9nIs.jpg\" alt=\"\" width=\"400\" height=\"329\"></span></p>",
      "unique_key": "Q4563700",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561349,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The structure marked 1 and 4 are the anterior ethmoidal artery and posterior ethmoidal artery, which are branches of the ophthalmic division of the internal carotid artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vascular Supply of the Nasal Cavity:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/32_vngPIsW.jpg\" alt=\"\" width=\"700\" height=\"722\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 198</strong></span></p>",
      "correct_choice_id": 17175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61097,
      "choices": [
        {
          "id": 243669,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Natural skin folds that align with relaxed muscle tension</span></span></span></p>"
        },
        {
          "id": 243670,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Collagen fiber alignment lines used in wound healing prediction</span></span></span></p>"
        },
        {
          "id": 243671,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lines of facial expression that guide botulinum toxin injections</span></span></span></p>"
        },
        {
          "id": 243672,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anatomical landmarks indicating major blood vessels under the skin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 34-year-old woman consults a plastic surgeon regarding a planned facelift. She expresses concern about the potential for visible scarring after the surgery and inquires about techniques that minimize scarring. The surgeon discusses the process and importance of aligning incision along Kraissl&rsquo;s line to optimize healing and achieve the best cosmetic results. What are Kraissl&rsquo;s lines, and what is their significance in surgical practice?</span></span></span></p>",
      "unique_key": "Q6066462",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561350,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp; A. Natural skin folds that align with relaxed muscle tension</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kraissl&rsquo;s lines, also known as relaxed skin tension lines (RSTLs), are natural skin folds that align with relaxed muscle tension. These lines guide surgeons in placing incisions in cosmetic and reconstructive surgery to ensure the least visible scarring. Kraissl&rsquo;s lines are determined by the natural resting state of the skin and are especially useful in areas such as the face, where minimizing scar visibility is crucial. They differ from other lines, like Langer&rsquo;s lines, which are based on dermal collagen orientation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Collagen fiber alignment lines used in wound healing prediction:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This refers to Langer&rsquo;s lines, which are based on the natural orientation of collagen fibers in the dermis. Langer&rsquo;s lines guide incisions in a different context but are not the same as Kraissl&rsquo;s lines.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option C. Lines of facial expression that guide botulinum toxin injections:</strong> These are dynamic lines formed by repeated facial muscle movements, often targeted in aesthetic treatments like botulinum toxin injections but are not relevant to surgical incision planning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Anatomical landmarks indicating major blood vessels under the skin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This describes vascular landmarks that guide surgeries to avoid major blood vessels, which are not related to Kraissl&rsquo;s lines and have no impact on scar minimization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/picture4.jpg\" style=\"height:456px; width:400px\" /></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kraissl&rsquo;s lines are natural skin folds that reflect areas of minimal tension and are used by surgeons to plan incisions for optimal cosmetic outcomes. Properly aligning incisions with these lines helps reduce visible scarring, making them crucial in cosmetic and reconstructive procedures.</span></span></span></p>",
      "correct_choice_id": 243669,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4304,
      "choices": [
        {
          "id": 17193,
          "text": "<p><span style=\"font-size:12.0pt;\">Bezold abscess</span></p>"
        },
        {
          "id": 17194,
          "text": "<p><span style=\"font-size:12.0pt;\">Griesinger's sign</span></p>"
        },
        {
          "id": 17195,
          "text": "<p><span style=\"font-size:12.0pt;\">Battle's sign</span></p>"
        },
        {
          "id": 17196,
          "text": "<p><span style=\"font-size:12.0pt;\">Delta sign</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is absent in a case of otitis media among the options provided? (</span>INICET Nov 2020)</p>",
      "unique_key": "Q9949895",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561351,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Battle's sign</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Battle's sign, characterized by ecchymosis (bruising) over the mastoid process, is typically indicative of a basilar skull fracture, specifically fractures involving the temporal bone. It is not associated with otitis media, which is an infection or inflammation of the middle ear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture34.jpg\" alt=\"\" width=\"300\" height=\"310\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bezold abscess</strong>: This abscess is a serious complication of otitis media. It occurs when the infection spreads from the mastoid process into the surrounding tissues, leading to a collection of pus.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_U12kS2b.png\" width=\"368\" height=\"436\"></p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Griesinger's sign:</strong> This sign is associated with lateral sinus thrombosis, a rare but severe complication of otitis media and mastoiditis. It involves tenderness and swelling behind the ear and along the mastoid bone.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VzbRqdT.png\" width=\"268\" height=\"281\"></p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Delta sign:</strong> Also related to lateral sinus thrombosis, the Delta sign typically appears on contrast-enhanced imaging studies as a NON enhancement at thrombosed area of sinus, a complication arising from otitis media.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_E3iSA6N.png\" width=\"294\" height=\"281\"></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While otitis media can lead to various complications, including Bezold abscess and lateral sinus thrombosis (indicated by Griesinger’s sign and Delta sign), Battle's sign is not associated with this condition. Instead, Battle's sign should prompt an evaluation for temporal bone fractures, emphasizing the importance of distinguishing between signs of infection and trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 87, 93, 507</strong></span></p>",
      "correct_choice_id": 17195,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5210,
      "choices": [
        {
          "id": 20813,
          "text": "<p><span style=\"font-size:12.0pt;\">Meatoplasty</span></p>"
        },
        {
          "id": 20814,
          "text": "<p><span style=\"font-size:12.0pt;\">Tympanoplasty</span></p>"
        },
        {
          "id": 20815,
          "text": "<p><span style=\"font-size:12.0pt;\">Myringoplasty</span></p>"
        },
        {
          "id": 93272,
          "text": "<p><span style=\"font-size:12.0pt;\">Otoplasty</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the surgery done to widen the cartilaginous part of the external auditory canal called?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
      "unique_key": "Q8468180",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561352,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Meatoplasty</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The surgery done to widen the cartilaginous part of the external auditory canal is meatoplasty.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is performed in combination with all canal wall down procedures like modified radical and radical mastoidectomies, for the treatment of middle ear disease such as cholesteatoma. The widened meats help easily visualize and access the mastoid cavity for periodic inspection and cleaning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is also done as an isolated procedure in elderly people with sagging auricle. Sagging auricle causes obstruction to the meatus leading to retention of wax and difficulty in hearing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> Tympanoplasty is the surgical reconstruction to correct damage in the middle ear and restore the integrity of the tympanic membrane for improved hearing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Myringoplasty refers to the reconstruction of the tympanic membrane only.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> A cosmetic or reconstructive procedure aimed at correcting deformities or defects of the external part of the ear (pinna).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Meatoplasty is an important surgical option for managing conditions that require improved access to the ear canal and middle ear, particularly in managing chronic ear diseases or anatomical changes that impact ear function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 32, 457, 463</strong></span></p>",
      "correct_choice_id": 20813,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54233,
      "choices": [
        {
          "id": 216401,
          "text": "<p><span style=\"font-size:12.0pt;\">Allergic shiners</span></p>"
        },
        {
          "id": 216402,
          "text": "<p><span style=\"font-size:12.0pt;\">Allergic salute</span></p>"
        },
        {
          "id": 216403,
          "text": "<p><span style=\"font-size:12.0pt;\">Otto veraguth folds</span></p>"
        },
        {
          "id": 216404,
          "text": "<p><span style=\"font-size:12.0pt;\">Dennis Morgan lines</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following signs is not typically seen in allergic rhinitis?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5802908",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561353,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p style=\"text-align:justify;\">Ans.&nbsp;C) Otto veraguth folds</p><p style=\"text-align:justify;\">Allergic rhinitis is a condition characterized by symptoms such as sneezing, nasal congestion, runny nose, and itchy eyes. These symptoms can lead to several physical signs due to chronic inflammation and repetitive actions like rubbing the nose and eyes. However we do not see Otto Veraguth folds in Allergic Rhinitis.</p><p style=\"text-align:justify;\">&nbsp;Also known as Veraguth folds, these are small creases on the upper eyelid and are not related to allergic rhinitis. They are typically associated with individuals suffering from depression, not allergic conditions.</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Y3dgMpj.png\" width=\"165\" height=\"99\"></p><p style=\"text-align:justify;\">Other Options:</p><p style=\"text-align:justify;\">Option A. Allergic Shiners: Commonly seen in allergic rhinitis due to venous congestion under the eyes.</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VmOZacZ.png\" alt=\"Allergic shiner - Wikipedia\" width=\"208\" height=\"156\"></p><p style=\"text-align:justify;\">Option B. Allergic Salute: A habitual action in allergic rhinitis leading to a nasal crease.</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7en3pIB.jpeg\" alt=\"Allergic salute - Wikipedia\" width=\"205\" height=\"136\"></p><p style=\"text-align:justify;\">Option D. Dennis Morgan Lines: Found in chronic allergic conditions due to persistent inflammation and edema, including allergic rhinitis.</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sA2tzDh.png\" width=\"163\" height=\"151\"></p><p style=\"text-align:justify;\">Educational Objective:&nbsp;</p><p style=\"text-align:justify;\">Otto Veraguth folds are not associated with allergic rhinitis but are more commonly seen in individuals with depression.</p><p style=\"text-align:justify;\">&nbsp;</p>",
      "correct_choice_id": 216403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4429,
      "choices": [
        {
          "id": 17693,
          "text": "<p><span style=\"font-size:12.0pt;\">a-1, b-2, c-3, d-4</span></p>"
        },
        {
          "id": 17694,
          "text": "<p><span style=\"font-size:12.0pt;\">a-2, b-3, c-4, d-1</span></p>"
        },
        {
          "id": 17695,
          "text": "<p><span style=\"font-size:12.0pt;\">a-2, b-4, c-3, d-1</span></p>"
        },
        {
          "id": 17696,
          "text": "<p><span style=\"font-size:12.0pt;\">a-1, b-3, c-4, d-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following:&nbsp;</span>(INICET NOVEMBER 2021)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/untitled-21.jpg\" alt=\"\" width=\"600\" height=\"229\"></p>",
      "unique_key": "Q4388612",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561354,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) a-2, b-4, c-3, d-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct match for Wullstein’s classification is a-2, b-4, c-3, d-1</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Type II – 2. graft placed over the incus</span></li><li><span style=\"font-size:12.0pt;\">Type III – 4. columella tympanoplasty</span></li><li><span style=\"font-size:12.0pt;\">Type IV – 3. Cavum minor</span></li><li><span style=\"font-size:12.0pt;\">Type V – 1. Fenestration tympanoplasty</span></li></ol><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Type II (Ossiculoplasty)</strong>: Malleus partially eroded; ossicular chain reconstruction involves placing a graft over the incus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type III (Columella Effect)</strong>: Malleus and incus eroded; new TM coupled to the stapes head, referred to as columella tympanoplasty.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type IV (Cavum Minor)</strong>: Stapedial head also eroded; new TM and new ossicular coupling to the stapes footplate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type V (Fenestration Operation)</strong>: Creating a fenestra and coupling the ossicular chain to the scala vestibuli.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wullstein’s classification of tympanoplasty provides a systematic approach to different types of middle ear reconstructions based on the extent of ossicular damage and required surgical repair.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_m0R8vHp.png\" width=\"781\" height=\"552\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-115802.png\" alt=\"\" width=\"1000\" height=\"480\"></p>",
      "correct_choice_id": 17695,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4333,
      "choices": [
        {
          "id": 17309,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of nasal polyps</span></p>"
        },
        {
          "id": 17310,
          "text": "<p><span style=\"font-size:12.0pt;\">Eosinophilic mucin without invasion</span></p>"
        },
        {
          "id": 17311,
          "text": "<p><span style=\"font-size:12.0pt;\">Characteristic CT findings</span></p>"
        },
        {
          "id": 17312,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive fungal culture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are major diagnostic criteria for allergic fungal sinusitis except? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q7016972",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561355,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Positive fungal culture</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A positive fungal culture is a minor diagnostic criterion for allergic fungal rhinosinusitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This classification was detailed by Bent and Kuhn, who established criteria based on their findings of several clinical features important for the diagnosis of AFRS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Presence of nasal polyps:&nbsp;</strong>Polyps are a common and significant finding in AFRS, often contributing to the blockage and symptoms of sinusitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Eosinophilic mucin:&nbsp;</strong>A hallmark of AFRS, this refers to thick, peanut butter-like mucin with eosinophils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Characteristic CT findings:&nbsp;</strong>These include hyperdense areas within the sinuses, which are indicative of fungal involvement and mucin accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-22%20134220.jpg\" width=\"1267\" height=\"586\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bent and Kuhn described a diagnostic criterion for AFRS. They found 11 important clinical features, 5 of which were termed major criteria and the remaining 6 features as minor criteria. These criteria includes:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Scott Brown 8<sup>th</sup> edition, Volume 1, Page No. 1049</strong></span></p>",
      "correct_choice_id": 17312,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6893,
      "choices": [
        {
          "id": 27540,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibition of M2 receptor</span></span></span></p>"
        },
        {
          "id": 27541,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Neuraminidase inhibition</span></span></span></p>"
        },
        {
          "id": 27542,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibition of RNA dependent DNA polymerase</span></span></span></p>"
        },
        {
          "id": 27543,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Apoptosis of infected cells</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of action of Oseltamivir as an antiviral agent is? (</span></span>AIIMS Nov 2017)</p>",
      "unique_key": "Q5169251",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561356,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Neuraminidase inhibition</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oseltamivir, commonly known by its brand name Tamiflu, is an antiviral medication primarily used to treat and prevent Influenza A and B. Its mechanism of action is as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Neuraminidase inhibition</span></strong><span style=\"font-size:12.0pt\">: Oseltamivir works by inhibiting the viral enzyme neuraminidase. Neuraminidase is crucial for the viral life cycle because it cleaves sialic acid residues on the surface of host cells and on viral proteins, which facilitates the release of new viral particles from infected cells. By inhibiting neuraminidase, Oseltamivir prevents the release and spread of the virus, thus limiting the infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Inhibition of M2 receptor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. The M2 receptor is targeted by another antiviral drug, Amantadine, which is used against influenza A by inhibiting viral uncoating.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Inhibition of RNA dependent DNA polymerase:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Inhibition of RNA-dependent DNA polymerase is the mechanism of action for antiretroviral drugs like reverse transcriptase inhibitors used in HIV treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Apoptosis of infected cells:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Inducing apoptosis of infected cells is not the mechanism by which Oseltamivir works. It primarily prevents the release of new viral particles rather than directly inducing cell death.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oseltamivir is a neuraminidase inhibitor that is used to treat Influenza A and B. Inhibition of viral neuraminidase inhibits the release of viral progeny from the infected host cells.</span></span></span></p>",
      "correct_choice_id": 27541,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20269,
      "choices": [
        {
          "id": 81037,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral stenosis</span></p>"
        },
        {
          "id": 81038,
          "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid stenosis</span></p>"
        },
        {
          "id": 81039,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral regurgitation</span></p>"
        },
        {
          "id": 81040,
          "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid regurgitation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old female patient came with complaints of chest pain, palpitation, and shortness of breath. On examination, a mid-diastolic murmur was heard, and a prominent 'a' wave was found on JVP. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
      "unique_key": "Q9216676",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561357,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Tricuspid stenosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of a mid-diastolic murmur and a prominent 'a' wave in the jugular venous pressure (JVP) are key indicators for diagnosing tricuspid stenosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tricuspid Stenosis</strong> causes an obstruction to right ventricular inflow, which leads to an increase in right atrial pressure, reflected as a prominent 'a' wave in the JVP. The mid-diastolic murmur is due to the turbulent flow across the narrowed tricuspid valve during diastole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mitral Stenosis:</strong> While it can cause a diastolic murmur, it typically does not cause a prominent 'a' wave in the JVP unless there is secondary pulmonary hypertension affecting the right side of the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mitral Regurgitation:</strong> This would cause a holosystolic murmur and, if severe enough to cause pulmonary hypertension, may indirectly cause changes in the JVP, but it does not directly cause a prominent 'a' wave.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tricuspid Regurgitation:</strong> This condition causes a large 'v' wave in the JVP due to backflow of blood into the right atrium during systole, not a prominent 'a' wave.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A prominent 'a' wave in JVP and a mid-diastolic murmur are indicative of tricuspid stenosis, a condition causing right ventricular inflow obstruction.</span></p>",
      "correct_choice_id": 81038,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13750,
      "choices": [
        {
          "id": 54961,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior</span></p>"
        },
        {
          "id": 54962,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior</span></p>"
        },
        {
          "id": 54963,
          "text": "<p><span style=\"font-size:12.0pt;\">Median</span></p>"
        },
        {
          "id": 54964,
          "text": "<p><span style=\"font-size:12.0pt;\">Lateral</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following lobes of the prostate forms the uvula vesicae?&nbsp;</span>(NEET PG 2019)</p>",
      "unique_key": "Q2653903",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561358,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Median</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The uvula vesicae is formed by the prostate's median lobe.</span></li><li><span style=\"font-size:12.0pt;\">The uvula vesicae is a slight elevation on the trigone immediately posterior to the urethral orifice caused by the median lobe of the prostate.</span></li><li><span style=\"font-size:12.0pt;\">In benign prostatic hypertrophy, it is frequently enlarged.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-921.jpg\" alt=\"\" width=\"700\" height=\"506\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anterior</strong>:&nbsp;The anterior lobe of the prostate, also referred to as the anterior fibromuscular stroma, is found at the front of the prostate, facing the pubic symphysis. Contrary to the other sections of the prostate, this area is primarily made up of fibromuscular tissue and contains fewer glandular elements. It doesn't commonly give rise to clinical conditions like benign prostatic hyperplasia (BPH) or prostate cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Posterior</strong>:&nbsp;The posterior lobe is located at the back of the prostate, facing the rectum. This part of the prostate is significant clinically because it's the most common site for the development of prostate cancer. During a digital rectal exam, the physician can palpate this lobe, and any firm or irregular nodules felt here could suggest malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Lateral</strong>:&nbsp;The lateral lobes are the large bilateral portions of the prostate on either side of the urethra. These are the most voluminous parts of the prostate and are typically the primary sites involved in benign prostatic hyperplasia (BPH), a common condition in older men where the prostate enlarges and can cause urinary obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The middle lobe or median lobe of the prostate is situated between the ejaculatory ducts and the urethra. When the median lobe enlarges due to conditions like benign prostatic hyperplasia (BPH), it can project into the bladder, forming a structure called the \"uvula vesicae.\" It is also known as Lietaud’s uvula. This growth can cause urinary symptoms by obstructing the bladder neck.</span></p>",
      "correct_choice_id": 54963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10069,
      "choices": [
        {
          "id": 40242,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholesterolosis</span></p>"
        },
        {
          "id": 40243,
          "text": "<p><span style=\"font-size:12.0pt;\">Gallbladder polyp</span></p>"
        },
        {
          "id": 40244,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma gallbladder</span></p>"
        },
        {
          "id": 40245,
          "text": "<p><span style=\"font-size:12.0pt;\">Strawberry gallbladder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was diagnosed for Cholelithiasis and underwent cholecystectomy. What would be the diagnosis according to the given image below?</span> <span style=\"font-size:12.0pt;\">(INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/8.jpg\" alt=\"\" width=\"300\" height=\"219\"></span></p>",
      "unique_key": "Q5957385",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561359,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Gallbladder polyp</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given image shows a Gall bladder specimen revealing numerous polyps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Gall Bladder Polyp</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Majority are either adenomyomatosis or cholesterol polyps and have no malignant potential.</span></p><p><span style=\"font-size:12.0pt;\">True adenomatous polyp occurs in 0.3–0.5% of the population. The risk of malignant transformation increases with increasing size of the polyp.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cholesterosis&nbsp;</strong>and<strong> Option D. Strawberry Gall bladder</strong>: The interior of the gallbladder looks something&nbsp;like a strawberry. The yellow specks (submucous aggregations of cholesterol crystals and cholesterol esters) correspond to the seeds of a strawberry.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture2.jpg\" alt=\"\" width=\"300\" height=\"347\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gall bladder Carcinoma</strong>: Gall bladder Carcinoma specimen resemble chronic cholecystitis on gross examination, often with a thickened wall and possibly a mass. However, the image provided does not show the characteristics typically associated with carcinoma, such as a mass or irregular thickening.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture3.jpg\" alt=\"\" width=\"300\" height=\"173\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gallbladder polyps, as seen in the image, are common and typically benign, with the risk of malignancy increasing with polyp size. Accurate identification is crucial for appropriate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 79, 1709</strong></span></p>",
      "correct_choice_id": 40243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10494,
      "choices": [
        {
          "id": 41942,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non-Hodgkin&#39;s lymphoma, RS cell, EBV</span></span></span></p>"
        },
        {
          "id": 41943,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Kaposi sarcoma, Giant cell, HIV</span></span></span></p>"
        },
        {
          "id": 41944,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hodgkin&#39;s lymphoma, RS cell, EBV</span></span></span></p>"
        },
        {
          "id": 41945,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Infectious mononucleosis, RS cell, CMV</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 6-year-old boy came with bilateral cervical lymphadenopathy. What is the probable diagnosis, cell, and virus associated with the image given below? (</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AIIMS&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">NOV 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(</span><span style=\"font-size:12.0pt\">RS cell: Reed - Sternberg cell, HIV: Human immunodeficiency virus, CMV: Cytomegalovirus, EBV: Epstein-Barr virus</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-398.jpg\" style=\"height:246px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q6623810",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561360,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hodgkin&#39;s lymphoma, RS cell, EBV</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The probable diagnosis, cell, and virus from the given clinical scenario and the histopathological image are Hodgkin&#39;s lymphoma, Reed-Sternberg cells (RS cells), and Epstein-Barr virus (EBV) respectively.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identification of Reed-Sternberg cells and their variants is essential for the diagnosis of Hodgkin&rsquo;s lymphoma. Diagnostic Reed-Sternberg cells are large cells (&ge;45 &mu;m in diameter) with multiple nuclei or a single nucleus with multiple nuclear lobes, each with a large inclusion-like nucleolus about the size of a small lymphocyte (5&ndash;7 &mu;m in diameter).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-04-181612.png\" style=\"height:642px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Non-Hodgkin&#39;s lymphoma, RS cell, EBV</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Non-Hodgkin&#39;s lymphoma does not typically feature Reed-Sternberg cells. While EBV can be associated with some types of Non-Hodgkin&#39;s lymphoma, the presence of RS cells is specific to Hodgkin&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Kaposi sarcoma, Giant cell, HIV</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Kaposi sarcoma is associated with human herpesvirus 8 (HHV-8) and often presents with spindle cells and slit-like vascular spaces, not Reed-Sternberg cells. It is more commonly associated with HIV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Infectious mononucleosis, RS cell, CMV</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Infectious mononucleosis is usually associated with EBV, not CMV, and while it can cause atypical lymphocytosis, it does not produce Reed-Sternberg cells, which are specific to Hodgkin&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hodgkin&#39;s lymphoma&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is characterized by the presence of <strong>Reed-Sternberg (RS) cells</strong>, and it is often associated with <strong>Epstein-Barr virus (EBV)</strong>, particularly in specific subtypes.</span></span></span></p>",
      "correct_choice_id": 41944,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20498,
      "choices": [
        {
          "id": 81954,
          "text": "<p><span style=\"font-size:12pt;\">Complete androgen insensitivity syndrome</span></p>"
        },
        {
          "id": 81955,
          "text": "<p><span style=\"font-size:12pt;\">Hypergonadotropic hypogonadism</span></p>"
        },
        {
          "id": 81956,
          "text": "<p><span style=\"font-size:12pt;\">Turner syndrome</span></p>"
        },
        {
          "id": 81957,
          "text": "<p><span style=\"font-size:12pt;\">Polycystic ovary syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old girl is seen for primary amenorrhea. She has not development of breasts or hair in the pubic or axillary region. Her height is 155cm and her weight is 48 kg. She has bilateral inguinal masses. On USG examination, the uterus, fallopian tube, and ovary are absent. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
      "unique_key": "Q6160855",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561940,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Hypergonadotropic hypogonadism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The diagnosis based on the given clinical scenario is hypergonadotropic hypogonadism.</span></li><li><span style=\"font-size:12pt;\">In this question, bilateral inguinal masses (undescended testis), absent ovary, also there is absent uterus and fallopian tubes, all pointing to a conclusion that patient can be of XY karyotype. Because if female reproductive tract is absent, there must be mullerian inhibiting substance present which comes from Y chromosome.</span></li><li><span style=\"font-size:12pt;\">Hypergonadotropic hypogonadism can occur in disorders such as FSH or LH receptor mutations.</span></li><li><span style=\"font-size:12pt;\">Now, in a XY individual with a defect in LH/hCG receptor, testis’ Sertoli cells will produce Anti-mullerian hormone which will not let uterus, fallopian tube, cervix, upper vagina to develop. Leydi cells will not produce testosterone due to which wolffian duct development is impaired and the testes fail to descend. They appear female at birth and at puberty present with primary amenorrhea. They lack breast development and pubic hair development.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Complete androgen insensitivity syndrome</strong>: Androgen insensitivity syndrome individuals have normal breast development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Turner syndrome</strong>: Turner's syndrome karyotype is XO.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Polycystic ovary syndrome</strong>: In Polycystic ovarian syndrome (PCOS) ovary and uterus is present, so can’t be answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hypergonadotropic hypogonadism can present as primary amenorrhea with absent uterus, fallopian tubes, and ovaries in an XY individual, with bilateral inguinal masses indicating undescended testes.</span></p>",
      "correct_choice_id": 81955,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54677,
      "choices": [
        {
          "id": 218173,
          "text": "<p><span style=\"font-size:12.0pt;\">A patient who is in acute crisis</span></p>"
        },
        {
          "id": 218174,
          "text": "<p><span style=\"font-size:12.0pt;\">A patient with cognitive deficits</span></p>"
        },
        {
          "id": 218175,
          "text": "<p><span style=\"font-size:12.0pt;\">A patient who is severely ill with deficient ego functioning</span></p>"
        },
        {
          "id": 218176,
          "text": "<p><span style=\"font-size:12.0pt;\">A patient with strong ego and high motivation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following patients, supportive psychotherapy would not be preferred? (INICET MAY 2024)</span></p>",
      "unique_key": "Q4147719",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561941,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) A patient with strong ego and high motivation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A patient with strong ego and high motivation:&nbsp;</strong>Advanced psychoanalysis are advised due to the patient's capacity for deep psychological work. Supportive psychotherapy, which focuses on immediate coping, is considered less effective for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Supportive psychotherapy is aimed at supporting the patient through reassurance, guidance, and a therapeutic relationship without delving deeply into their past or cognitive processes. It is particularly useful for patients in acute crisis, those with cognitive deficits, and severely ill patients with deficient ego functioning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. A patient who is in acute crisis:</strong> Supportive psychotherapy is highly appropriate as it focuses on providing immediate support and reassurance without exploring complex underlying issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. A patient with cognitive deficits:</strong> These patients may struggle to understand more intricate forms of psychotherapy, making supportive psychotherapy a suitable option to provide essential support and stabilization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. A patient who is severely ill with deficient ego functioning:</strong> These patients often have low frustration tolerance and cannot handle the complexities of other forms of therapy, making supportive psychotherapy beneficial to provide stability and support.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Supportive psychotherapy is not preferred for patients with a strong ego and high motivation, as they can handle and benefit from more complex and deeper forms of therapy.</span></p>",
      "correct_choice_id": 218176,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11420,
      "choices": [
        {
          "id": 45646,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">1<sup>1/2 </sup>hours</span></p>"
        },
        {
          "id": 45647,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">2<sup>1/2 </sup>hours</span></p>"
        },
        {
          "id": 45648,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">3<sup>1/2 </sup>hours</span></p>"
        },
        {
          "id": 45649,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">4<sup>1/2 </sup>hours</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">What is the window period for thrombolysis in case of stroke? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q1187614",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561942,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 4<sup>1/2</sup> hours</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The window period for the administration of intravenous recombinant tissue plasminogen activator (rtPA) in the case of an acute ischemic stroke is 4½ hours from the onset of symptoms. This time frame is critical as rtPA is most effective when administered early, aiming to dissolve the blood clot and restore blood flow to the affected part of the brain, thus minimizing or reversing the damage caused by the stroke.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Indications:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">After Clinical diagnosis of stroke established</span></li><li><span style=\"color:black;font-size:12.0pt;\">If onset of symptoms to time of drug administration &lt;/= 4.5 hours</span></li><li><span style=\"color:black;font-size:12.0pt;\">If age &gt;/= 18 years</span></li><li><span style=\"color:black;font-size:12.0pt;\">CT scan showing no hemorrhage or edema of &gt;1/3<sup>rd</sup> of the MCA territory</span></li><li><span style=\"color:black;font-size:12.0pt;\">Consent given by patient or surrogate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Contraindications:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Coma/stupor/ recent MI.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Major surgery in last 14 days/ GI bleeding in last 21 days/ minor stroke symptoms.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Rapidly improving symptoms.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Sustained BP &gt; 185/110 mmHg despite treatment.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Platelets &lt; 100,000; HCT &lt; 25%; glucose &lt; 50 or &gt; 400 mg/dL.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Use of heparin within 48hrs and prolonged PTT or elevated INR.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Prior stroke or head injury within 3 months; prior intracranial hemorrhage.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The therapeutic window for thrombolysis in acute ischemic stroke using rtPA is up to 4½ hours from symptom onset, and strict criteria must be met to ensure the safety and efficacy of treatment. This timeframe is crucial for maximizing the potential benefits of the treatment while minimizing risks.</span></p>",
      "correct_choice_id": 45649,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43280,
      "choices": [
        {
          "id": 172787,
          "text": "<p><span style=\"font-size:12.0pt;\">45%&nbsp;</span></p>"
        },
        {
          "id": 172788,
          "text": "<p><span style=\"font-size:12.0pt;\">27%&nbsp;</span></p>"
        },
        {
          "id": 172789,
          "text": "<p><span style=\"font-size:12.0pt;\">36%</span></p>"
        },
        {
          "id": 172790,
          "text": "<p><span style=\"font-size:12.0pt;\">31.5%&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Calculate for Burn Surface Area (BSA) for a patent with burn involving the chest and abdomen right arm and right thigh (circumferental): (INICET Nov 2023)</span></p>",
      "unique_key": "Q5414191",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561943,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 31.5%&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to the ‘Rule of Nine’, BSA is calculated as:&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Chest and Abdomen = 18%</span></li><li><span style=\"font-size:12.0pt;\">Right Arm (not entire upper limb) = 4.5%</span></li><li><span style=\"font-size:12.0pt;\">Right Thigh = 9%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Total = 18% + 4.5% + 9% = 31.5%</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Rule of Nines is a method used to estimate the total body surface area affected by burns. It divides the body into sections that represent approximately 9% of the total surface area, facilitating quick and effective assessment and treatment planning for burn patients.</span></p>",
      "correct_choice_id": 172790,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10219,
      "choices": [
        {
          "id": 40842,
          "text": "<p><span style=\"font-size:18px;\">Full course of tetanus vaccination</span></p>"
        },
        {
          "id": 40843,
          "text": "<p><span style=\"font-size:18px;\">Single dose tetanus toxoid</span></p>"
        },
        {
          "id": 40844,
          "text": "<p><span style=\"font-size:18px;\">Tetanus toxoid + immunoglobulin</span></p>"
        },
        {
          "id": 40845,
          "text": "<p><span style=\"font-size:18px;\">No vaccination needed</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A patient arrives with a clean-cut injury, no lacerations. He reports receiving his last tetanus vaccination approximately a decade ago. What would be the recommended course of action?</strong><i><strong> [NEET PG 2020]</strong></i></span></p>",
      "unique_key": "Q9316361",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561944,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Single dose tetanus toxoid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The recommended course of action for a patient with a clean-cut injury who received their last tetanus vaccination approximately a decade ago is to administer a single dose of tetanus toxoid. This recommendation is based on the standard guidelines for tetanus prophylaxis in wound management.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-173902.jpg\" alt=\"\" width=\"800\" height=\"380\"></span></p>",
      "correct_choice_id": 40843,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44786,
      "choices": [
        {
          "id": 178791,
          "text": "<p><span style=\"font-size:12pt;\">Dapagliflozin</span></p>"
        },
        {
          "id": 178792,
          "text": "<p><span style=\"font-size:12pt;\">Pioglitazone</span></p>"
        },
        {
          "id": 178793,
          "text": "<p><span style=\"font-size:12pt;\">Sitagliptin</span></p>"
        },
        {
          "id": 178794,
          "text": "<p><span style=\"font-size:12pt;\">Metformin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-diabetic drug is associated with increased risk of urinary tract infections? (</span>INICET May 2024)</p>",
      "unique_key": "Q4462466",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561945,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Dapagliflozin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Dapagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor. SGLT2 inhibitors work by promoting the excretion of glucose through the urine. This increased urinary glucose can create an environment that promotes the growth of bacteria, thereby increasing the risk of urinary tract infections. This class of drugs is well known for its association with UTIs and genital infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Pioglitazone</strong>:&nbsp;Pioglitazone is a thiazolidinedione that improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects include weight gain, edema, and an increased risk of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Sitagliptin</strong>:&nbsp;Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing incretin levels, which in turn increase insulin secretion and decrease glucagon secretion. Sitagliptin is not commonly associated with an increased risk of urinary tract infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Metformin</strong>:&nbsp;Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects of metformin include gastrointestinal disturbances such as diarrhea and abdominal discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, dapagliflozin, an SGLT2 inhibitor, is associated with an increased risk of urinary tract infections due to its mechanism of increasing glucose excretion in the urine. This patient’s recurrent UTIs could be related to her use of dapagliflozin.</span></p>",
      "correct_choice_id": 178791,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7571,
      "choices": [
        {
          "id": 30252,
          "text": "<p><span style=\"font-size:12pt;\">Telogen effluvium</span></p>"
        },
        {
          "id": 30253,
          "text": "<p><span style=\"font-size:12pt;\">Androgenetic alopecia</span></p>"
        },
        {
          "id": 30254,
          "text": "<p><span style=\"font-size:12pt;\">Alopecia areata</span></p>"
        },
        {
          "id": 30255,
          "text": "<p><span style=\"font-size:12pt;\">Trichotillomania</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the probable diagnosis for a 38-year-old female who is experiencing substantial hair loss for 4 months and has a history of COVID-19 infection 8 months ago?&nbsp;</span>(NEET PG 2022)</p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/07/picture6.jpg\" alt=\"\" width=\"300\" height=\"347\"></span></p>",
      "unique_key": "Q4609841",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561946,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><i><strong>Ans.</strong></i></span><span style=\"color:#0782c1;font-size:12pt;\"><i><strong>&nbsp;</strong></i></span><span style=\"font-size:12pt;\"><strong>A. Telogen effluvium</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The pattern of hair loss in this clinical scenario is <strong>telogen effluvium</strong>.</span></li><li><span style=\"font-size:12pt;\">The condition described is characterized by the <strong>sudden onset of scalp hair loss, typically occurring one to two months</strong> <strong>after a triggering event</strong>, which may include high fever, <strong>infections</strong> (such as Cholera, Typhoid, or COVID-19), <strong>surgery, trauma</strong>, starvation, <strong>myocardial infarction (MI), pregnancy, or hemorrhage</strong>.</span></li><li><span style=\"font-size:12pt;\">This type of hair loss is associated with an <strong>increase in the shedding of telogen club hairs due to the premature termination of the anagen proliferative phase</strong> of the hair cycle following a period of significant <strong>stress.</strong></span></li><li><span style=\"font-size:12pt;\">When telogen hair shedding lasts for more than six months, it is termed <strong>“chronic diffuse telogen hair loss.”</strong> The main causes of <strong>chronic diffuse telogen hair loss</strong> include <strong>thyroid</strong> conditions (both hyper- and hypothyroidism), severe iron deficiency <strong>anemia</strong>, <strong>acrodermatitis enteropathica</strong>, and malnutrition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Androgenetic alopecia: </strong>Typically presents as a patterned hair loss and is more gradual. It is driven by genetic factors and hormonal influences and does not usually have a sudden onset associated with illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Alopecia areata:</strong></span></p><ul><li><span style=\"font-size:12pt;\">An <strong>autoimmune</strong> condition where the body's immune system <strong>attacks</strong> <strong>hair follicles.</strong></span></li><li><span style=\"font-size:12pt;\">It results in small, round, and <strong>smooth patches</strong> of hair loss, which can coalesce but often do <strong>not cause complete hair loss</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture1_A3XGSmK.jpg\" alt=\"\" width=\"400\" height=\"267\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It's not directly linked to illnesses like COVID-19 and does not typically present as diffuse hair loss across the entire scalp as suggested in the question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Trichotillomania:</strong></span></p><ul><li><span style=\"font-size:12pt;\">A psychological condition where individuals <strong>compulsively pull out</strong> their own hair, leading to hair loss.</span></li><li><span style=\"font-size:12pt;\">Hair loss pattern tends to be <strong>irregular</strong> with varied length hairs, and examination often reveals <strong>broken hairs.</strong></span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture2.jpg\" alt=\"\" width=\"400\" height=\"281\"></strong></i></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The history provided does not suggest any compulsive behavior or the typical patchy, irregular pattern seen with trichotillomania.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Telogen effluvium is a form of non-scarring hair loss characterized by the diffuse shedding of hair resulting from the early entry of hair into the telogen phase (the resting phase of the hair cycle). This condition is often triggered by significant physiological stress, severe illness, or major life events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Reference: Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 89 page no 32.24, 32.39, 32.40, 86.17, 89.6, 89.14, 89.17, 89.20 89.24, 89.25, 89.46</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Fitzpatrick’s dermatology 9<sup>th</sup> edition page 1509</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrisons principles of internal medicine 21<sup>st</sup> edition 387</strong></span></p>",
      "correct_choice_id": 30252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24675,
      "choices": [
        {
          "id": 98661,
          "text": "<p>4</p>"
        },
        {
          "id": 98662,
          "text": "<p>2</p>"
        },
        {
          "id": 98663,
          "text": "<p>1</p>"
        },
        {
          "id": 98664,
          "text": "<p>3</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The vestibulo-ocular reflex (VOR) functions to stabilize the image on the retina during head movement. What is the ratio of eye velocity to head velocity, known as the VOR gain?&nbsp;</span>&nbsp;(INICET May 2023)</p>",
      "unique_key": "Q5521757",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561947,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The vestibulo-ocular reflex (VOR) gain is 1, indicating that the eyes move at a compensatory velocity equal to the velocity of the head, but in the opposite direction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The vestibulo-ocular reflex (VOR) allows for eye movements in the opposite direction of head movement to maintain steady gaze and prevent retinal image slip. Nerves involved are <strong>3, 6 &amp; 8.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct VOR gain is crucial for visual stability. A gain of 1 allows for precise compensation for head movements, ensuring that the visual environment remains stable, which is vital for tasks that involve motion and require steady vision, such as reading while in a moving vehicle or playing sports.</span></p>",
      "correct_choice_id": 98663,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11452,
      "choices": [
        {
          "id": 45774,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic acidosis with respiratory compensation</span></span></span></span></p>"
        },
        {
          "id": 45775,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory acidosis with metabolic compensation</span></span></span></span></p>"
        },
        {
          "id": 45776,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory alkalosis with metabolic compensation</span></span></span></span></p>"
        },
        {
          "id": 45777,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic alkalosis with respiratory compensation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The arterial blood gas findings of a patient are pH = 7.32, pCO2 = 50, HCO3- = 29. What is the diagnosis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q4116510",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561948,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Respiratory acidosis with metabolic compensation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s arterial blood gas (ABG) results indicate:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pH = 7.12 (&lt;7.4 = acidemic/acidosis) &rarr; Metabolic vs respiratory (pCO2 &gt; 40= Respiratory drive is towards acidosis while metabolic [HCO3-] is towards alkalosis) &rarr; Respiratory acidosis with metabolic compensation (Every 10 &uarr; pCO2 = &uarr;4 HCO3- = Chronic).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These findings are characteristic of <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">respiratory acidosis with metabolic compensation</span></strong>. In respiratory acidosis, the body compensates by increasing renal reabsorption of bicarbonate to buffer the excess hydrogen ions resulting from elevated CO2 levels, which shifts the pH back towards normal. This compensation is a slower process and suggests a chronic respiratory condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases where ABG shows a low pH and high pCO2 with compensatory high bicarbonate, the diagnosis is typically respiratory acidosis with metabolic compensation. This is indicative of a chronic condition where the body adjusts bicarbonate levels to buffer the increased acidity due to CO2 retention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Acid-Base Disturbances</span></span></strong></span></span></p>",
      "correct_choice_id": 45775,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4195,
      "choices": [
        {
          "id": 16759,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrogen peroxide</span></span></span></p>"
        },
        {
          "id": 16760,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Penicillin</span></span></span></p>"
        },
        {
          "id": 16761,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Methyl paraben</span></span></span></p>"
        },
        {
          "id": 16762,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bleaching powder</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following agents can be used as a disinfectant but not a sanitizer? (INICET MAY 2022)</span></span></p>",
      "unique_key": "Q2076876",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561949,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Hydrogen peroxide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Process of bringing down levels of pathogenic organisms on inanimate surfaces to reduce the chances of cross-infection is called as sanitization.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Process of destroying all pathogenic organisms is called as disinfection.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Process of eliminating all microorganisms in both vegetative and spore state are eliminated from a surface or medium is called as sterilization.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrogen peroxide works by producing destructive hydroxyl free radicals that can attack membrane lipids, DNA, and other essential cell components. Catalase, produced by aerobic organisms and facultative anaerobes that possess cytochrome systems, can protect cells from metabolically produced hydrogen peroxide by degrading hydrogen peroxide to water and oxygen. This defense is overwhelmed by the concentrations used for disinfection.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Disinfection or sterilization of cystoscopes, endoscopes, tubing&rsquo;s, and metal instruments can be done with liquid form of hydrogen peroxide while gaseous form can be used for fogging. It is also used in plasma sterilization.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Penicillin, </strong>an antibiotic. It is neither a disinfectant nor a sanitizer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Methyl paraben</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a type of paraben. Parabens are chemicals that are often used as preservatives to give products a longer shelf life.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Household bleaching powder (sodium hypochlorite</strong>) is used as a disinfectant<strong> </strong>in hospitals. Diluted solutions can be used for sanitizing surfaces.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hydrogen peroxide</span></strong><span style=\"font-size:12.0pt\"> is used as a disinfectant because it effectively destroys a wide range of pathogenic organisms. It is not typically used as a sanitizer, which is a process aimed at reducing, rather than completely eliminating, pathogenic organisms on surfaces.</span></span></span></p>",
      "correct_choice_id": 16759,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2446,
      "choices": [
        {
          "id": 9770,
          "text": "<p><span style=\"font-size:12.0pt;\">L- gulonolactone oxidase</span></p>"
        },
        {
          "id": 9771,
          "text": "<p><span style=\"font-size:12.0pt;\">Xylitol reductase</span></p>"
        },
        {
          "id": 9772,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate dehydrogenase</span></p>"
        },
        {
          "id": 9773,
          "text": "<p><span style=\"font-size:12.0pt;\">UDP glucose dehydrogenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C cannot be produced in humans due to lack of? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q7782871",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561950,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) L-gulonolactone oxidase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Most animals and plants can synthesize ascorbic acid from glucose. Man, higher primates, guineapigs and bats are the only species which cannot synthesize ascorbic acid (block in <strong>gulonolactone oxidase step</strong>). They lack the genes responsible for the synthesis of this enzyme.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Details of L-gulonolactone Oxidase:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Role:</strong> This enzyme is responsible for converting L-gulonolactone to ascorbic acid (vitamin C).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deficiency:</strong> Humans, higher primates, guinea pigs, and certain other species lack this enzyme due to mutations or absence of the gene encoding it, which blocks the synthesis of ascorbic acid.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Xylitol reductase:</strong> This enzyme is involved in the metabolism of xylitol to xylulose but is not related to the synthesis of vitamin C.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Pyruvate dehydrogenase:</strong> This enzyme complex plays a critical role in converting pyruvate to acetyl-CoA in cellular respiration but is not involved in vitamin C synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>UDP glucose dehydrogenase:</strong> This enzyme is involved in the synthesis of UDP-glucuronic acid from UDP-glucose but has no role in vitamin C production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">Humans cannot synthesize vitamin C due to the lack of the enzyme L-gulonolactone oxidase, which is necessary for the final step in the biosynthetic pathway of ascorbic acid from glucose.</span></p>",
      "correct_choice_id": 9770,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10032,
      "choices": [
        {
          "id": 40094,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renal failure</span></span></span></p>"
        },
        {
          "id": 40095,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Accumulation of calcium phosphate</span></span></span></p>"
        },
        {
          "id": 40096,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin D deficiency</span></span></span></p>"
        },
        {
          "id": 40097,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Parathyroid activation secretion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following conditions are associated with Metastatic calcification except: (INICET Nov 2022)</span></span></p>",
      "unique_key": "Q6266647",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561951,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Vitamin D deficiency</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metastatic calcification is associated with Hypercalcemia (Vitamin D toxicity), not Vitamin D deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-131920.jpg\" style=\"height:403px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumors having Dystrophic calcification: Psammoma bodies present</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">M &ndash; M</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">eningioma, <strong>M</strong>esothelioma</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">O &ndash; O</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">vary (Serous cystadenoma)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">S &ndash; S</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">alivary gland tumor</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">T &ndash; T</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">hyroid (Papillary thyroid cancer)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P &ndash; P</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">rolactinoma</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">G &ndash; G</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">lucagonoma</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Renal failure</span></strong><span style=\"font-size:12.0pt\">: Chronic kidney disease can lead to secondary hyperparathyroidism and hyperphosphatemia, both of which contribute to hypercalcemia and subsequent metastatic calcification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Accumulation of calcium phosphate</span></strong><span style=\"font-size:12.0pt\">: This typically occurs in the context of renal failure or parathyroid hormone-related issues, leading to metastatic calcification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D Parathyroid activation secretion</span></strong><span style=\"font-size:12.0pt\">: Hyperparathyroidism, whether primary or secondary, causes an increase in serum calcium, leading to metastatic calcification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metastatic calcification is associated with conditions that lead to hypercalcemia, not with conditions that result in normal or low calcium levels, such as Vitamin D deficiency.</span></span></span></p>",
      "correct_choice_id": 40096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11334,
      "choices": [
        {
          "id": 45302,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetic ketoacidosis</span></span></p>"
        },
        {
          "id": 45303,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent vomiting</span></span></p>"
        },
        {
          "id": 45304,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Septic shock</span></span></p>"
        },
        {
          "id": 45305,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal tubular acidosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arterial blood gas (ABG) report shows the following findings:</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2021)</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">pH: 7.52</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HCO3: 30 mEq/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PaCO2: 45 mmHg</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Na: 123 mEq/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">K: 3.2 mEq/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cl: 67 mEq/L</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the cause of her ABG findings? </span></span></p>",
      "unique_key": "Q1753141",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561952,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Persistent vomiting</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ABG report indicates the patient has <strong>metabolic alkalosis</strong>, as evidenced by the elevated pH (7.52) and increased bicarbonate (HCO3) level (30 mEq/L). The slight increase in PaCO2 (45 mmHg) is a compensatory response to metabolic alkalosis, as the body attempts to retain CO2 to balance the pH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Persistent vomiting leads to a loss of gastric acid (HCl), which results in metabolic alkalosis. The electrolyte disturbances seen here (hypokalemia, hypochloremia, and hyponatremia) are typical of persistent vomiting. Vomiting causes a loss of hydrogen ions (leading to increased bicarbonate), chloride (hypochloremia), and potassium (hypokalemia), along with fluid loss, which can dilute serum sodium levels, leading to hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Diabetic ketoacidosis:</span></strong><span style=\"font-size:12.0pt\"> Diabetic ketoacidosis (DKA) typically presents with metabolic acidosis (low pH and low HCO3) rather than metabolic alkalosis. Additionally, DKA is usually associated with hyperkalemia rather than hypokalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Septic shock:</span></strong><span style=\"font-size:12.0pt\"> Septic shock usually causes metabolic acidosis due to lactic acidosis from poor tissue perfusion. It does not typically present with metabolic alkalosis and the specific electrolyte disturbances seen here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Renal tubular acidosis:</span></strong><span style=\"font-size:12.0pt\"> Renal tubular acidosis (RTA) is characterized by a defect in the kidneys&#39; ability to acidify the urine, leading to metabolic acidosis. The ABG findings in RTA would show a low pH and low bicarbonate levels, which is opposite to what is observed in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent vomiting can lead to hypokalemic, hypochloremic metabolic alkalosis with hyponatremia. This is due to the loss of gastric acid and electrolytes, and the characteristic ABG findings include elevated pH and bicarbonate levels. Treatment often involves fluid and electrolyte replacement, particularly with normal saline to correct chloride levels.</span></span></p>",
      "correct_choice_id": 45303,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9942,
      "choices": [
        {
          "id": 39734,
          "text": "<p><span style=\"font-size:12.0pt;\">Gynecomastia and long limbs</span></p>"
        },
        {
          "id": 39735,
          "text": "<p><span style=\"font-size:12.0pt;\">Flat occiput</span></p>"
        },
        {
          "id": 39736,
          "text": "<p><span style=\"font-size:12.0pt;\">Webbing of neck and lymphedema</span></p>"
        },
        {
          "id": 39737,
          "text": "<p><span style=\"font-size:12.0pt;\">Short stature and polydactyly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following feature is correct on the basis of given karyotype?</span> <span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/18.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p>",
      "unique_key": "Q1933152",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561953,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) Gynecomastia and long limbs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given karyotyping image shows '47, XXY' abnormality, which is seen in Klinefelter's syndrome.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-173214.png\" alt=\"\" width=\"583\" height=\"765\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Flat occiput</strong>: This feature is typically seen in <strong>Down syndrome</strong> (Trisomy 21).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Webbing of neck and lymphedema</strong>: These are characteristic features of <strong>Turner syndrome</strong> (45, X).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Short stature and polydactyly</strong>: These are features seen in <strong>Patau syndrome</strong> (Trisomy 13).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Klinefelter syndrome (47, XXY) is characterized by gynecomastia, long limbs, small testes, and infertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and cotran pathologic basis of disease 8<sup>th</sup> edition pg 316-317</strong></span></p>",
      "correct_choice_id": 39734,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11484,
      "choices": [
        {
          "id": 45902,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in Systolic blood pressure 20 mmHg after 6 mins of standing</span></p>"
        },
        {
          "id": 45903,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in Diastolic blood pressure 20 mmHg after 6 mins of standing</span></p>"
        },
        {
          "id": 45904,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in Systolic blood pressure 20 mmHg after 3 min of standing</span></p>"
        },
        {
          "id": 45905,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in diastolic blood pressure 20 mmHg after 3 mins of standing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">True about the definition of Postural Hypotension: (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q7708891",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561954,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Decrease in systolic blood pressure 20 mm Hg after 3 mins of standing</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>“3-20-10”</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12pt;\">mnemonic can aid in remembering the definition of orthostatic hypotension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sustained fall of SBP &gt; 20mmHg /DBP &gt; 10mmHg after 3 mins of standing. Usually, it is accompanied by a rise in HR.&nbsp;<strong>Absence of increase in heart rate suggest neurogenic/autonomic dysfunction</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Cause of Orthostatic Hypotension:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Cardiac pump failure</span></li><li><span style=\"font-size:12.0pt;\">Hypovolemia</span></li><li><span style=\"font-size:12.0pt;\">Endocrinopathies: AI, Pheochromocytoma.</span></li><li><span style=\"font-size:12.0pt;\">Venous pooling</span></li><li><span style=\"font-size:12.0pt;\">Medications</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A and B:&nbsp;</strong>These options extend the timing to 6 minutes, which is not standard for the initial assessment of orthostatic hypotension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:&nbsp;</strong>Specifies a diastolic drop which should be 10 mmHg, not 20 mmHg, thus making it incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Postural hypotension, also known as orthostatic hypotension, is defined as a significant drop in blood pressure when a person stands up from a sitting or lying position. The correct definition, as per the consensus, includes a decrease in systolic blood pressure of 20 mmHg or a decrease in diastolic blood pressure of 10 mmHg within 3 minutes of standing. The answer C correctly reflects the component of this definition regarding the systolic blood pressure drop.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cardiology, chap 21/695</strong></span></p>",
      "correct_choice_id": 45904,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4212,
      "choices": [
        {
          "id": 16825,
          "text": "<p><span style=\"font-size:12.0pt;\">Enterotoxigenic Escherichia coli</span></p>"
        },
        {
          "id": 16826,
          "text": "<p><span style=\"font-size:12.0pt;\">Enteropathogenic Escherichia coli</span></p>"
        },
        {
          "id": 16827,
          "text": "<p><span style=\"font-size:12.0pt;\">Enteroinvasive Escherichia coli</span></p>"
        },
        {
          "id": 16828,
          "text": "<p><span style=\"font-size:12.0pt;\">Diffusely adherent Escherichia coli</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which pathogen causes attachment-effacement lesion in the intestinal mucosa?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2021)</span></p>",
      "unique_key": "Q1971568",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561955,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) Enteropathogenic Escherichia coli</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Attaching-and-effacing is the “hallmark” of the EPEC infections, a lesion that is characterized by the intimate attachment of the bacteria to the host epithelial cell membrane and the effacement of the microvilli. This mechanism is a hallmark of EPEC infections, leading to copious watery diarrhea, especially in infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Enterotoxigenic Escherichia coli (ETEC):</strong></span>&nbsp;<span style=\"font-size:12.0pt;\"><strong>Incorrect:</strong> ETEC causes watery diarrhea through the production of enterotoxins that increase cyclic AMP (cAMP) or cyclic GMP (cGMP) levels, leading to fluid and electrolyte loss. It does not cause attachment-effacement lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Enteroinvasive Escherichia coli (EIEC):&nbsp;Incorrect:</strong> EIEC invades and destroys epithelial cells lining the colon, leading to fever, cramping, watery diarrhea, and dysentery with scant, bloody stools. It does not cause attachment-effacement lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diffusely adherent Escherichia coli (DAEC):&nbsp;Incorrect:</strong> DAEC is known for its diffuse adherence pattern to epithelial cells, causing persistent diarrhea in children. It does not cause attachment-effacement lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/02/screenshot-2024-07-02-171808.png\" alt=\"\" width=\"1000\" height=\"818\"></p>",
      "correct_choice_id": 16826,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61138,
      "choices": [
        {
          "id": 243833,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Waters view</span></span></span></p>"
        },
        {
          "id": 243834,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caldwell view</span></span></span></p>"
        },
        {
          "id": 243835,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Towne view</span></span></span></p>"
        },
        {
          "id": 243836,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lateral view</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 42-year-old man presents to the clinic with persistent headaches and facial pressure that have progressively worsened over the past month. The pain is primarily located around his forehead and the bridge of his nose, worsening when he bends forward. He has no history of recent trauma and denies any significant nasal discharge or fever. Suspecting sinusitis, the physician orders a specific radiographic view to best evaluate his frontal sinuses along with other nearby structures. What is the commonly used name for this specific radiographic view?</span></span></span></p>",
      "unique_key": "Q3339608",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561956,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: B. Caldwell view</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Caldwell view, also known as the occipitofrontal view, is specifically designed for optimal visualization of the frontal sinuses. This view is obtained by positioning the patient&rsquo;s forehead and nose against the radiographic film with the X-ray beam angled 15&ndash;20&deg; caudally. This technique provides detailed imaging of the frontal sinuses, ethmoid sinuses, superior orbital fissure, and other related structures, making it ideal for evaluating sinus conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Waters view:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This view is primarily used to assess the maxillary sinuses and does not provide the optimal angle for visualizing the frontal sinuses. It involves positioning that differs from the Caldwell view, focusing more on the infraorbital region.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Towne view:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The Towne view is utilized for examining the occipital region and posterior cranial fossa, not specifically for sinus evaluation, and does not target the frontal sinuses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Lateral view:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The lateral view provides a side profile of the skull, including the sinuses, but lacks the angulation and detail required for optimal assessment of the frontal sinuses, unlike the Caldwell view.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Caldwell view is the preferred radiographic technique for evaluating the frontal sinuses due to its specific positioning and angulation, which provide detailed visualization of this area. Understanding which radiographic view is best suited for different anatomical structures is crucial for accurate diagnosis and management of sinus-related conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/picture5_OvbtWZI.jpg\" style=\"height:1096px; width:900px\" /></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/picture-5-2_VaDuDJ5.jpg\" style=\"height:1014px; width:900px\" /></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/picture5-3.jpg\" style=\"height:1119px; width:900px\" /><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/picture-5-4.jpg\" style=\"height:1167px; width:900px\" /></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/picture-5-5.jpg\" style=\"height:320px; width:900px\" /></p>",
      "correct_choice_id": 243834,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9908,
      "choices": [
        {
          "id": 39598,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">2, 4</span></span></span></p>"
        },
        {
          "id": 39599,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">1, 2, 3</span></span></span></p>"
        },
        {
          "id": 39600,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">2, 3, 4</span></span></span></p>"
        },
        {
          "id": 39601,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">1, 2, 4</span></span></span></p>"
        }
      ],
      "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Blood examination shows pancytopenia, which can be correct? </span></span></span>(AIIMS NOV 2020)</p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Megaloblastic anemia </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Hairy cell leukemia </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">MDS with hypocellular BM </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">APML</span></span></span></li>\r\n</ol>",
      "unique_key": "Q9117173",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561957,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 1, 2, 3</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Megaloblastic anemia (hypocellular phase), hairy cell leukemia, and MDS (hypocellular bone marrow) can show pancytopenia. </span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Megaloblastic anemia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This type of anemia, often caused by vitamin B12 or folate deficiency, can lead to pancytopenia, especially in its more severe or hypocellular phase. The bone marrow in megaloblastic anemia can show hypercellularity with ineffective hematopoiesis, but in some cases, it can present as hypocellular, contributing to pancytopenia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hairy cell leukemia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a type of chronic B-cell lymphoproliferative disorder. It is commonly associated with pancytopenia due to bone marrow infiltration by hairy cells and associated fibrosis, which suppresses normal hematopoiesis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MDS with hypocellular BM:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Myelodysplastic syndromes (MDS) are a group of hematologic conditions characterized by ineffective hematopoiesis and dysplasia in one or more of the myeloid cell lines. In cases of MDS with a hypocellular bone marrow, pancytopenia can occur due to the reduced production of blood cells.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. Acute promyelocytic leukemia (APML)</span></strong><span style=\"font-size:12.0pt\"> is typically not associated with pancytopenia. APML usually presents with leukocytosis or normal white cell counts, along with thrombocytopenia and anemia. However, severe pancytopenia is not a characteristic feature, and therefore, APML is not typically associated with pancytopenia.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Causes of pancytopenia &ndash; </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">I. <strong>Aplastic anemia</strong> </span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">II. <strong>Pancytopenia with normal or increased marrow cellularity e.g.</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Myelodysplastic syndromes</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Hypersplenism</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Megaloblastic anemia</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">III<strong>. Paroxysmal nocturnal hemoglobinuria (page 314</strong>)</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">IV<strong>. Bone marrow infiltrations e.g.</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Hematologic malignancies (<u>leukemias, lymphomas, myeloma</u>)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Non-hematologic metastatic malignancies</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Storage diseases</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Osteopetrosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Myelofibrosis</span></span></span></li>\r\n</ol>",
      "correct_choice_id": 39599,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32073,
      "choices": [
        {
          "id": 128162,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LH</span></span></span></span></p>"
        },
        {
          "id": 128163,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin</span></span></span></span></p>"
        },
        {
          "id": 128164,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TSH</span></span></span></span></p>"
        },
        {
          "id": 128165,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TRH</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following binds to tyrosine kinase receptors?(NEET PG 2020)</span></span></p>",
      "unique_key": "Q6019166",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561958,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Insulin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Insulin:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin binds to tyrosine kinase receptors known as insulin receptors (IR). When insulin binds to these receptors, it activates the tyrosine kinase activity of the receptor, resulting in the autophosphorylation of tyrosine residues and the initiation of intracellular signaling cascades. Therefore, insulin binds to tyrosine kinase receptors.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. LH (Luteinizing Hormone):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LH does not directly bind to tyrosine kinase receptors. LH binds to its specific G-protein-coupled receptor (LH receptor) on the surface of target cells, leading to the activation of intracellular signaling pathways via G proteins.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. TSH (Thyroid-Stimulating Hormone):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TSH does not directly bind to tyrosine kinase receptors. TSH binds to the thyroid-stimulating hormone receptor (TSHR), which belongs to the family of G-protein-coupled receptors. Activation of TSHR leads to intracellular signaling through G proteins, not tyrosine kinase activation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. TRH (Thyrotropin-Releasing Hormone):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TRH does not directly bind to tyrosine kinase receptors. It acts on its specific G-protein-coupled receptor (TRH receptor) to initiate signaling pathways through G proteins, similar to TSH.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong><strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The insulin and IGF-I receptors have intrinsic ligand-activated tyrosine kinase activity. By binding to these receptors, these hormones will activate tyrosine kinases inside the cell which in turn phosphorylates important enzymes for involved in a number of processes such as metabolism, growth and differentiation and also inflammatory response.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref- Harper 31st ed./pg</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &ndash; <strong>508</strong></span></span></span></span></p>",
      "correct_choice_id": 128163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54661,
      "choices": [
        {
          "id": 218109,
          "text": "<p><span style=\"font-size:12.0pt;\">Pure red cell aplasia</span></p>"
        },
        {
          "id": 218110,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrops fetalis</span></p>"
        },
        {
          "id": 218111,
          "text": "<p><span style=\"font-size:12.0pt;\">Aplastic crisis</span></p>"
        },
        {
          "id": 218112,
          "text": "<p><span style=\"font-size:12.0pt;\">Petechial rash</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not caused by parvovirus B19?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8463744",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561959,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) Petechial rash</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parvovirus B19 is known to cause several conditions, including erythema infectiosum (fifth disease), which presents with a characteristic \"slapped cheek\" rash in children. It can also affect red blood cells, leading to pure red cell aplasia and aplastic crisis, especially in individuals with underlying hemolytic disorders. In pregnant women, parvovirus B19 infection can cause hydrops fetalis, a serious condition characterized by severe fetal anemia and fluid accumulation. However, petechial rash is not typically associated with parvovirus B19 infection. Petechial rashes are more commonly linked to other viral infections or conditions that cause thrombocytopenia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pure red cell aplasia:</strong> Parvovirus B19 can infect erythroid progenitor cells in the bone marrow, leading to pure red cell aplasia, particularly in individuals with compromised immune systems or underlying hematologic disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hydrops fetalis:</strong> Parvovirus B19 infection during pregnancy can lead to hydrops fetalis due to severe fetal anemia, making this a well-documented complication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aplastic crisis:</strong> In individuals with chronic hemolytic anemias, such as sickle cell disease, parvovirus B19 infection can precipitate an aplastic crisis by temporarily halting red blood cell production in the bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parvovirus B19 can cause pure red cell aplasia, aplastic crisis, and hydrops fetalis, but it is not associated with petechial rash.</span></p>",
      "correct_choice_id": 218112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InstrumentsBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6534,
      "choices": [
        {
          "id": 26105,
          "text": "<p><span style=\"font-size:12.0pt;\">Clozapine</span></p>"
        },
        {
          "id": 26106,
          "text": "<p><span style=\"font-size:12.0pt;\">Donepezil</span></p>"
        },
        {
          "id": 26107,
          "text": "<p><span style=\"font-size:12.0pt;\">Selegiline</span></p>"
        },
        {
          "id": 26108,
          "text": "<p><span style=\"font-size:12.0pt;\">Haloperidol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly man presents with rigidity and tremors. On examination, he has blank facial expressions. Which of the following drugs can be used to manage this condition? (NEET PG 2022)</span></p>",
      "unique_key": "Q7492175",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561961,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Selegiline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of rigidity, tremors, and blank facial expressions are suggestive of Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. Selegiline is a monoamine oxidase B (MAO-B) inhibitor that is used in the management of Parkinson's disease. It works by inhibiting the breakdown of dopamine, thereby increasing its availability in the brain and helping to alleviate symptoms like rigidity and tremors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Clozapine</strong>: Clozapine is an atypical antipsychotic primarily used in the treatment of schizophrenia. While it can be used in Parkinson's disease patients who experience psychosis, it is not a first-line treatment for the primary motor symptoms of Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Donepezil</strong>: Donepezil is an acetylcholinesterase inhibitor used in the treatment of Alzheimer’s disease. It enhances cholinergic function by increasing the concentration of acetylcholine in the brain. It is not typically used for treating Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Haloperidol</strong>: Haloperidol is a typical antipsychotic and can actually worsen Parkinson's disease symptoms. It blocks dopamine receptors, which could exacerbate the dopamine deficiency characteristic of Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Selegiline is a monoamine oxidase B (MAO-B) inhibitor that increases dopamine availability in the brain and is used to manage the motor symptoms of Parkinson's disease, such as rigidity and tremors.</span></p>",
      "correct_choice_id": 26107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24737,
      "choices": [
        {
          "id": 98909,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-nuclear antibodies</span></span></span></p>"
        },
        {
          "id": 98910,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glucose tolerance test</span></span></span></p>"
        },
        {
          "id": 98911,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Audiometry</span></span></span></p>"
        },
        {
          "id": 98912,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Echocardiography</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the subsequent options is non-essential in the evaluation of mosaic Turner syndrome?</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
      "unique_key": "Q7242650",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561962,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Anti-nuclear antibodies </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Out of the provided choices, the presence of anti-nuclear antibodies is not a necessary factor when investigating mosaic Turner syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mosaic Turner syndrome is non-hereditary in nature. It emerges from a chance incident during the phase of cell division in the initial stages of fetal development in the impacted individual. Consequently, a portion of an individual&#39;s cells retain the standard two sex chromosomes, whereas another set of cells possess just a single X chromosome copy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Features of Turner Syndrome:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-125693.jpg\" style=\"height:637px; width:484px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Glucose Tolerance Test</span></strong><span style=\"font-size:12.0pt\">: Important for detecting glucose intolerance or diabetes, which is common in Turner syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Audiometry</span></strong><span style=\"font-size:12.0pt\">: Used to assess hearing loss, which is more prevalent in individuals with Turner syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Echocardiography</span></strong><span style=\"font-size:12.0pt\">: Critical for evaluating congenital heart defects, such as coarctation of the aorta or bicuspid aortic valve, which are common in Turner syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While glucose tolerance testing, audiometry, and echocardiography are essential in the evaluation of Turner syndrome, testing for anti-nuclear antibodies is not necessary unless there is a clinical suspicion of an associated autoimmune disorder.</span></span></span></p>",
      "correct_choice_id": 98909,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7045,
      "choices": [
        {
          "id": 28148,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></span></p>"
        },
        {
          "id": 28149,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saxagliptin</span></span></span></p>"
        },
        {
          "id": 28150,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vildagliptin</span></span></span></p>"
        },
        {
          "id": 28151,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linagliptin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs does not need dose adjustment in renal failure? (</span></span>INICET May 2020)</p>",
      "unique_key": "Q1530757",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561963,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Linagliptin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the treatment of type 2 diabetes. Unlike other DPP-4 inhibitors, linagliptin is primarily excreted via the enterohepatic system, with only a small fraction eliminated by the kidneys. Therefore, it does not require dose adjustments in patients with renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Sitagliptin:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This DPP-4 inhibitor is primarily excreted by the kidneys, and its dose usually needs to be adjusted in patients with renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Saxagliptin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Saxagliptin and its active metabolite are primarily eliminated by the kidneys, necessitating dose adjustments in patients with renal failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vildagliptin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Vildagliptin is partially excreted by the kidneys, and dose adjustment is recommended in patients with moderate to severe renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linagliptin is a unique DPP-4 inhibitor that does not require dose adjustments in patients with renal failure due to its primary excretion via the enterohepatic system. This makes it an advantageous option for managing type 2 diabetes in patients with compromised renal function.</span></span></span></p>",
      "correct_choice_id": 28151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14437,
      "choices": [
        {
          "id": 57709,
          "text": "<p><span style=\"font-size:12pt;\">Triceps</span></p>"
        },
        {
          "id": 57710,
          "text": "<p><span style=\"font-size:12pt;\">Biceps</span></p>"
        },
        {
          "id": 57711,
          "text": "<p><span style=\"font-size:12pt;\">Sartorius</span></p>"
        },
        {
          "id": 57712,
          "text": "<p><span style=\"font-size:12pt;\">Brachioradialis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Mr. Seth recently underwent surgery to remove a parathyroid gland due to hyperparathyroidism. The surgeon informed the patient that one or more of the parathyroid glands may be transferred to another location during the surgery to protect them or due to their location. The parathyroid is commonly transferred to? (</span>NEET PG 2019)</p>",
      "unique_key": "Q2925520",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561964,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Brachioradialis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most common site for the relocation of the parathyroid gland(s) is in the forearm muscle, specifically the nondominant side brachioradialis. Transplantation to this location provides several advantages:</span></p><ul><li><span style=\"font-size:12pt;\"><strong>Accessibility</strong>: The forearm location is easily accessible for potential future surgical interventions if necessary.</span></li><li><span style=\"font-size:12pt;\"><strong>Monitoring</strong>: This location allows for straightforward monitoring of parathyroid function using simple clinical tests.</span></li><li><span style=\"font-size:12pt;\"><strong>Functionality</strong>: The transplanted gland(s) will continue to produce parathyroid hormone normally, aiding in the regulation of calcium levels in the body.</span></li><li><span style=\"font-size:12pt;\"><strong>Ease of Removal</strong>: If there is disease recurrence after surgery, the forearm location facilitates easy removal.</span></li><li><span style=\"font-size:12pt;\">Typically, a total of 12 to 14 pieces are transplanted in a type of heterotopic transplant.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Triceps:&nbsp;</strong>Triceps is not a preferred site for parathyroid transplantation due to less accessibility and monitoring challenges compared to the brachioradialis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Biceps:&nbsp;</strong>Biceps is also not commonly used for parathyroid transplantation because it does not offer the same ease of access and monitoring advantages as the brachioradialis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Sartorius:&nbsp;</strong>Sartorius is not a preferred site for parathyroid transplantation. The forearm muscle (brachioradialis) is favored for its convenience and monitoring benefits.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The brachioradialis muscle in the forearm is the most common site for parathyroid gland relocation during surgery due to its ease of access, convenient monitoring, and straightforward removal if needed.</span></p>",
      "correct_choice_id": 57712,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11627,
      "choices": [
        {
          "id": 46474,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MRI showing &lt; 1/3rd of MCA territorial infarct</span></span></span></p>"
        },
        {
          "id": 46475,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood pressure of &gt; 185/110 mmHg</span></span></span></p>"
        },
        {
          "id": 46476,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ischemia &lt; 2 hours</span></span></span></p>"
        },
        {
          "id": 46477,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Onset of symptoms &lt; 4 hours</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis can be considered in all of these conditions, except:</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q2949716",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561965,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Blood pressure of &gt; 185/110 mmHg</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood pressure of &gt; 185/110 mmHg: This is a contraindication for thrombolysis. Elevated blood pressure increases the risk of hemorrhagic complications during thrombolysis. Therefore, blood pressure must be controlled to below 185/110 mmHg before initiating thrombolytic therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis is a treatment used to dissolve blood clots in certain types of stroke patients. It is most effective when administered within a specific time window from the onset of symptoms and under certain conditions to ensure patient safety and efficacy of the treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. MRI showing &lt; 1/3rd of MCA territorial infarct:</span></strong><span style=\"font-size:12.0pt\"> This indicates that the infarct size is within a range that is generally considered safe for thrombolysis. More extensive infarcts (&gt; 1/3rd of the middle cerebral artery territory) are a contraindication due to the higher risk of hemorrhagic transformation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>C. Ischemia &lt; 2 hours and D. Onset of symptoms &lt; 4 hours</strong>: Both of these options fall within the critical time window for thrombolysis, which is generally considered up to 4.5 hours from symptom onset. Treatment within this time frame can significantly improve outcomes in stroke patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis is contraindicated in patients with blood pressure higher than 185/110 mmHg at the time of treatment.</span></span></span></p>",
      "correct_choice_id": 46475,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13073,
      "choices": [
        {
          "id": 52254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hostile</span></span></span></p>"
        },
        {
          "id": 52255,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Indirect</span></span></span></p>"
        },
        {
          "id": 52256,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Direct</span></span></span></p>"
        },
        {
          "id": 52257,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hearsay</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sameer was tried in a court in the case of Sanjay&rsquo;s murder in the park. Sahil appeared in court and stated that he saw Sameer with an axe in his hand while passing the park. What is this evidence known as? (</span></span>INICET Nov 2022)</p>",
      "unique_key": "Q4535551",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561966,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Indirect</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This type of evidence in known as an indirect evidence or circumstantial evidence.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This evidence providing only a basis for inference about the fact in dispute and it is not an eyewitness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hostile:</span></strong><span style=\"font-size:12.0pt\"> Refers to a witness who is antagonistic or adverse to the party who called them to testify.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Direct:</span></strong><span style=\"font-size:12.0pt\"> Evidence that directly proves a fact, such as an eyewitness account of the crime being committed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hearsay:</span></strong><span style=\"font-size:12.0pt\"> Evidence based on what someone else said, not on the direct knowledge of the witness, and typically inadmissible in court due to its second-hand nature.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Indirect or circumstantial evidence suggests a fact but does not directly prove it. In this case, seeing Sameer with an axe near the park suggests involvement but does not directly prove his guilt.</span></span></span></p>",
      "correct_choice_id": 52255,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14430,
      "choices": [
        {
          "id": 57681,
          "text": "<p><span style=\"font-size:12.0pt;\">Negative pressure wound therapy</span></p>"
        },
        {
          "id": 57682,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive pressure wound therapy</span></p>"
        },
        {
          "id": 57683,
          "text": "<p><span style=\"font-size:12.0pt;\">Foam therapy</span></p>"
        },
        {
          "id": 57684,
          "text": "<p><span style=\"font-size:12.0pt;\">Sponge therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with a large, deep wound and the healthcare provider decides to use a specific wound-healing procedure. What is the principle behind the wound-healing procedure shown in the image below?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-661.jpg\" alt=\"\" width=\"300\" height=\"229\"></span></p>",
      "unique_key": "Q2219626",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561967,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Negative pressure wound therapy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Negative pressure wound therapy, also known as vacuum-assisted closure (VAC) therapy, involves the application of negative pressure to a wound using a sealed dressing connected to a vacuum pump.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This therapy helps in wound healing by several mechanisms: it removes excess fluid and infectious materials from the wound, improves blood flow to the area, reduces edema (swelling), and promotes the formation of granulation tissue.</span></li><li><span style=\"font-size:12.0pt;\">It is often used for large, deep wounds, chronic wounds, and complex surgical wounds to accelerate the healing process.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">VAC therapy = vacuum assisted closure therapy</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Mechanism of action:&nbsp;</strong>VAC therapy involves the application of negative pressure (-125 mm of hg) to a wound to promote wound healing. The negative pressure removes excess fluid and promotes the formation of granulation tissue and new blood vessels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Indications:&nbsp;</strong>VAC therapy is commonly used for the management of complex wounds, such as diabetic foot ulcers, pressure ulcers, and surgical wounds. It can also be used to manage wounds with high risk of infection.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Procedure:&nbsp;</strong>VAC therapy involves placing a foam dressing over the wound and covering it with an adhesive film. A tube is then inserted through the film and connected to a vacuum pump, which applies negative pressure to the wound. The pressure can be adjusted to provide the optimal level of tension for the specific wound.</span></li></ol>",
      "correct_choice_id": 57681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6492,
      "choices": [
        {
          "id": 25937,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen</span></p>"
        },
        {
          "id": 25938,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisphosphonates</span></p>"
        },
        {
          "id": 25939,
          "text": "<p><span style=\"font-size:12.0pt;\">Raloxifene</span></p>"
        },
        {
          "id": 25940,
          "text": "<p><span style=\"font-size:12.0pt;\">Combined oral contraceptives</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old woman presents to the clinic for her annual check-up. Her DEXA scan shows evidence of osteoporosis with a T-score of -3.0 at the lumbar spine. She is postmenopausal and has no other significant medical history. She is interested in pharmacological treatment options for her osteoporosis. What is the first-line management for postmenopausal osteoporosis in this patient? (NEET PG 2020)</span></p>",
      "unique_key": "Q5086860",
      "question_audio": null,
      "question_video": null,
      "map_id": 13561968,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Bisphosphonates</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bisphosphonates, such as alendronate and risedronate, are often considered the first-line therapy for postmenopausal osteoporosis. These drugs inhibit bone resorption and have been shown to reduce the risk of fractures in postmenopausal women with osteoporosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Estrogen:</strong> While estrogen replacement therapy can be effective for preventing bone loss, it is generally not recommended as first-line treatment for osteoporosis due to potential risks, such as an increased risk of breast cancer, thromboembolic events, and cardiovascular disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Raloxifene:</strong> Raloxifene is a selective estrogen receptor modulator (SERM) that is sometimes used in osteoporosis treatment. It is not usually considered first-line treatment but may be an option for those who cannot tolerate bisphosphonates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Combined Oral Contraceptives:</strong> Combined oral contraceptives are not used for the treatment of postmenopausal osteoporosis. They are generally used in reproductive-age women for contraception and are not suitable for postmenopausal women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bisphosphonates are the first-line management for postmenopausal osteoporosis due to their effectiveness in inhibiting bone resorption and reducing fracture risk. Estrogen and raloxifene are alternative options but are not typically first-line treatments due to their associated risks and less robust efficacy compared to bisphosphonates. Combined oral contraceptives are not suitable for postmenopausal osteoporosis treatment.</span></p>",
      "correct_choice_id": 25938,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54781,
      "choices": [
        {
          "id": 218589,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxoplasma</span></p>"
        },
        {
          "id": 218590,
          "text": "<p><span style=\"font-size:12.0pt;\">Varicella</span></p>"
        },
        {
          "id": 218591,
          "text": "<p><span style=\"font-size:12.0pt;\">HSV</span></p>"
        },
        {
          "id": 218592,
          "text": "<p><span style=\"font-size:12.0pt;\">CMV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman with a history of painful genital ulcers 1 year back has a neonate of 1 week who has lesions on face and body with neurological symptoms. What is the likely infection? (INICET MAY 2024)</span></p>",
      "unique_key": "Q2766841",
      "question_audio": null,
      "question_video": null,
      "map_id": 13562277,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) HSV (Herpes Simplex Virus)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The question presents a scenario where a woman has a history of painful genital ulcers and has given birth to a neonate who now exhibits lesions on the face and body along with neurological symptoms. This clinical picture strongly suggests a neonatal herpes simplex virus (HSV) infection.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Herpes Simplex Virus (HSV)</strong> is known to cause painful genital ulcers in adults. The virus can remain latent in the body and reactivate later. During pregnancy or delivery, HSV can be transmitted to the neonate, particularly during vaginal delivery if there are active lesions or viral shedding. Neonatal HSV infection can present with vesicular lesions on the skin, eyes, and mouth, and it may also involve the central nervous system, leading to neurological symptoms. Neonatal HSV infection is a serious condition that requires prompt antiviral treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Toxoplasma:</strong> Incorrect because it does not cause painful genital ulcers in the mother or the described symptoms in the neonate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Varicella:</strong> Incorrect because, although it can cause skin lesions in neonates, it is not linked with a history of painful genital ulcers in the mother.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CMV:</strong> Incorrect because CMV can cause congenital infections with neurological symptoms, but it is not associated with painful genital ulcers in the mother.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A history of painful genital ulcers in the mother, especially when associated with neonatal lesions and neurological symptoms, is highly suggestive of neonatal HSV infection. HSV is a serious condition that requires immediate medical attention to prevent severe outcomes in the neonate.</span></p>",
      "correct_choice_id": 218591,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}